☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.


	(Unaudited)						(Unaudited)
	September 30,			December 31,			June 30,			December 31,
(In millions)	2021			2020			2022			2021
Assets
Current assets:
Cash and cash equivalents	$	105.8		$	103.3		$	99.2		$	127.7
Accounts receivable, net		176.6			125.4			234.2			160.3
Inventories, net		244.5			213.5			271.5			245.7
Contract assets		38.4			43.1			30.1			30.5
Prepaid expenses and other current assets		42.0			38.0			44.3			39.5
Assets held for sale		12.6			12.6			12.6			12.6
Total current assets		619.9			535.9			691.9			616.3

Property, plant and equipment		3,104.9			3,139.7			3,045.4			3,110.0
Less accumulated depreciation		(1,344.1	)		(1,265.5	)		(1,375.1	)		(1,363.9	)
Net property, plant and equipment		1,760.8			1,874.2			1,670.3			1,746.1

Goodwill and other intangible assets, net		269.9			277.8			258.8			267.5
Investments in affiliated companies		43.0			44.7			46.1			44.6
Other assets		179.0			185.2			152.3			144.9
Total assets	$	2,872.6		$	2,917.8		$	2,819.4		$	2,819.4

Liabilities and Stockholders' Equity
Current liabilities:
Short-term borrowings	$	0.9		$	0.9		$	0.5		$	0.9
Accounts payable		90.1			70.0			103.4			113.2
Accrued compensation and benefits		64.7			43.2			71.3			54.4
Financial instruments		2.4			3.6			20.7			5.7
Accrued liabilities		66.8			65.4			75.3			73.4
Total current liabilities		224.9			183.1			271.2			247.6

Long-term debt		876.4			925.5			812.0			822.4
Retirement obligations		53.2			53.9			48.7			52.6
Deferred income taxes		149.7			153.0			128.6			140.0
Other non-current liabilities		74.1			92.1			78.6			71.3
Total liabilities		1,378.3			1,407.6			1,339.1			1,333.9
Stockholders' equity:
Common stock, $0.01 par value, 200.0 shares authorized, 110.0 shares and 109.7 shares issued at September 30, 2021 and December 31, 2020, respectively		1.1			1.1
Common stock, $0.01 par value, 200.0 shares authorized, 110.3 shares and 110.1 shares issued at June 30, 2022 and December 31, 2021, respectively								1.1			1.1
Additional paid-in capital		873.4			849.7			894.1			878.6
Retained earnings		1,993.6			1,996.4			2,058.0			2,012.5
Accumulated other comprehensive loss		(93.8	)		(59.6	)		(191.3	)		(126.5	)
		2,774.3			2,787.6			2,761.9			2,765.7
Less – Treasury stock, at cost, 26.1 shares at September 30, 2021 and 26.1 shares at December 31, 2020.		(1,280.0	)		(1,277.4	)
Less – Treasury stock, at cost, 26.2 shares at June 30, 2022 and 26.1 shares at December 31, 2021								(1,281.6	)		(1,280.2	)
Total stockholders' equity		1,494.3			1,510.2			1,480.3			1,485.5
Total liabilities and stockholders' equity	$	2,872.6		$	2,917.8		$	2,819.4		$	2,819.4

The accompanying notes are an integral part of these condensed consolidated financial statements.


Hexcel Corporation and Subsidiaries
Condensed Consolidated Statements of Operations

	(Unaudited)					(Unaudited)						(Unaudited)						(Unaudited)
	Quarter Ended September 30,					Nine Months Ended September 30,						Quarter Ended June 30,						Six Months Ended June 30,
(In millions, except per share data)	2021		2020			2021			2020			2022			2021			2022			2021
Net sales	$	333.8	$	286.9		$	964.4		$	1,206.6		$	393.0		$	320.3		$	783.6		$	630.6
Cost of sales		267.8		273.4			783.4			997.3			303.5			258.4			607.4			515.6
Gross margin		66.0		13.5			181.0			209.3			89.5			61.9			176.2			115.0
Selling, general and administrative expenses		32.0		24.6			102.7			95.2			33.5			31.1			78.2			70.7
Research and technology expenses		10.4		10.7			33.5			36.0			11.3			11.5			22.2			23.1
Other operating expense		0.8		15.8			16.0			43.6
Operating income (loss)		22.8		(37.6	)		28.8			34.5
Other operating (income) expense													(19.1	)		3.1			(18.1	)		15.2
Operating income													63.8			16.2			93.9			6.0
Interest expense, net		9.5		9.7			29.1			32.4			8.9			9.3			18.0			19.6
Other income													(0.3	)		-			(0.3	)		-
Income (loss) before income taxes, and equity in earnings from affiliated companies		13.3		(47.3	)		(0.3	)		2.1			55.2			6.9			76.2			(13.6	)
Income tax expense (benefit)		5.1		(56.9	)		1.6			(48.7	)		12.7			4.0			17.4			(3.5	)
Income (loss) before equity in earnings from affiliated companies		8.2		9.6			(1.9	)		50.8			42.5			2.9			58.8			(10.1	)
Equity in earnings (losses) from affiliated companies		0.8		0.1			(0.9	)		0.3			2.2			(0.7	)		3.7			(1.7	)
Net income (loss)	$	9.0	$	9.7		$	(2.8	)	$	51.1		$	44.7		$	2.2		$	62.5		$	(11.8	)
Basic net income (loss) per common share	$	0.11	$	0.12		$	(0.03	)	$	0.61		$	0.53		$	0.03		$	0.74		$	(0.14	)
Diluted net income (loss) per common share	$	0.11	$	0.12		$	(0.03	)	$	0.61		$	0.53		$	0.03		$	0.74		$	(0.14	)
Weighted-average common shares:
Basic		84.1		83.8			84.1			83.7			84.4			84.1			84.3			84.0
Diluted		84.7		84.0			84.1			84.0			85.0			84.7			84.9			84.0

The accompanying notes are an integral part of these condensed consolidated financial statements.


	(Unaudited)						(Unaudited)
	Nine Months Ended September 30,						Six Months Ended June 30,
(In millions)	2021			2020			2022			2021
Cash flows from operating activities
Net (loss) income	$	(2.8	)	$	51.1
Reconciliation to net cash provided by operating activities:
Net income (loss)							$	62.5		$	(11.8	)
Reconciliation to net cash used by operating activities:
Depreciation and amortization		102.4			106.0			63.9			68.7
Amortization related to financing		2.7			0.7			0.4			2.1
Deferred income taxes		(3.2	)		(46.0	)		(4.1	)		(10.7	)
Equity in earnings from affiliated companies		0.9			(0.3	)
Equity in (earnings) losses from affiliated companies								(3.7	)		1.7
Stock-based compensation		16.2			13.0			12.8			13.3
Merger and restructuring expenses, net of payments		(4.4	)		13.3			(6.0	)		(2.5	)
Gain on sale of asset								(19.4	)		-
Gain on sale of investment								(0.3	)		-
Changes in assets and liabilities:
(Increase) decrease in accounts receivable		(55.6	)		81.0
(Increase) decrease in inventories		(37.3	)		74.2
Decrease in prepaid expenses and other current assets		3.6			1.5
Increase (decrease) in accounts payable/accrued liabilities		43.3			(128.0	)
Increase in accounts receivable								(74.5	)		(45.9	)
Increase in inventories								(38.9	)		(21.8	)
Increase in prepaid expenses and other current assets								(10.1	)		(2.6	)
Increase in accounts payable/accrued liabilities								28.4			50.7
Other – net		(1.6	)		(9.5	)		7.3			(2.3	)
Net cash provided by operating activities		64.2			157.0			18.3			38.9

Cash flows from investing activities
Capital expenditures		(15.0	)		(47.8	)		(37.9	)		(9.2	)
Proceeds from sale of asset								21.2			-
Proceeds from sale of investments								0.5			-
Net cash used for investing activities		(15.0	)		(47.8	)		(16.2	)		(9.2	)

Cash flows from financing activities
Repayments of Euro term loan		-			(49.9	)
Borrowing from senior unsecured credit facility - 2024		-			392.0			35.0			-
Repayment of senior unsecured credit facility - 2024		(49.0	)		(403.0	)		(46.0	)		(21.0	)
Repayment of finance lease obligation and other debt, net		(0.7	)		(0.4	)		(0.2	)		(0.4	)
Issuance costs related to senior credit facility		-			(1.3	)
Dividends paid		-			(14.2	)		(16.8	)		-
Repurchase of stock		-			(24.6	)
Activity under stock plans		4.9			(5.5	)		1.4			4.8
Net cash used for financing activities		(44.8	)		(106.9	)		(26.6	)		(16.6	)
Effect of exchange rate changes on cash and cash equivalents		(1.9	)		1.3			(4.0	)		(1.1	)
Net increase in cash and cash equivalents		2.5			3.6
Net (decrease) increase in cash and cash equivalents								(28.5	)		12.0
Cash and cash equivalents at beginning of period		103.3			64.4			127.7			103.3
Cash and cash equivalents at end of period	$	105.8		$	68.0		$	99.2		$	115.3
Supplemental data:
Accrual basis additions to plant, property and equipment	$	14.3		$	39.4		$	28.3		$	7.8

The accompanying notes are an integral part of these condensed consolidated financial statements.

For the ~~Three~~Quarter and ~~Nine~~Six Months ended ~~September~~June 30, ~~2021,~~2022, and ~~September~~June 30, ~~2020~~2021


									Accumulated
			Additional						Other						Total
			Paid-In			Retained			Comprehensive			Treasury			Stockholders’
(In millions)	Par		Capital			Earnings			Loss			Stock			Equity
Balance, December 31, 2019	$	1.1	$	829.9		$	1,978.9		$	(118.7	)	$	(1,245.1	)	$	1,446.1
Net income	—		—			42.4			—			—				42.4
Dividends paid on common stock ($0.17 per share)	—		—				(14.2	)	—			—				(14.2	)
Change in other comprehensive income (loss)– net of tax	—		—			—				(36.6	)	—				(36.6	)
Stock based compensation	—			15.2		—			—				(7.2	)		8.0
Acquisition of treasury stock	—		—			—			—				(24.6	)		(24.6	)
Balance, March 31, 2020	$	1.1	$	845.1		$	2,007.1		$	(155.3	)	$	(1,276.9	)	$	1,421.1
Net loss	—		—				(1.0	)	—			—				(1.0	)
Change in other comprehensive income (loss)– net of tax	—		—			—				17.3		—				17.3
Stock based compensation	—			(0.5	)	—			—			—				(0.5	)
Balance, June 30, 2020	$	1.1	$	844.6		$	2,006.1		$	(138.0	)	$	(1,276.9	)	$	1,436.9
Net income	—		—				9.7		—			—				9.7
Change in other comprehensive income (loss)– net of tax	—		—			—				52.8		—				52.8
Stock based compensation	—			0.5		—			—				(0.5	)	—
Balance, September 30, 2020	$	1.1	$	845.1		$	2,015.8		$	(85.2	)	$	(1,277.4	)	$	1,499.4


									Accumulated																Accumulated
			Additional						Other						Total					Additional					Other						Total
			Paid-In			Retained			Comprehensive			Treasury			Stockholders’					Paid-In		Retained			Comprehensive			Treasury			Stockholders’
(In millions)	Par		Capital			Earnings			Loss			Stock			Equity			Par		Capital		Earnings			Loss			Stock			Equity
Balance, December 31, 2020	$	1.1	$	849.7		$	1,996.4		$	(59.6	)	$	(1,277.4	)	$	1,510.2		$	1.1	$	849.7	$	1,996.4		$	(59.6	)	$	(1,277.4	)	$	1,510.2
Net loss	—		—				(14.0	)	—			—				(14.0	)	—		—			(14.0	)	—			—				(14.0	)
Change in other comprehensive income (loss)– net of tax	—		—			—				(19.1	)	—				(19.1	)
Change in other comprehensive (loss)– net of tax																		—		—		—				(19.1	)	—				(19.1	)
Stock based compensation	—			11.8		—			—				(2.0	)		9.8		—			11.8	—			—				(2.0	)		9.8
Balance, March 31, 2021	$	1.1	$	861.5		$	1,982.4		$	(78.7	)	$	(1,279.4	)	$	1,486.9		$	1.1	$	861.5	$	1,982.4		$	(78.7	)	$	(1,279.4	)	$	1,486.9
Net income	—		—				2.2		—			—				2.2		—		—			2.2		—			—				2.2
Change in other comprehensive income (loss)– net of tax	—		—			—				5.5		—				5.5
Change in other comprehensive income – net of tax																		—		—		—				5.5		—				5.5
Stock based compensation	—			8.2		—			—			—				8.2		—			8.2	—			—			—				8.2
Balance, June 30, 2021	$	1.1	$	869.7		$	1,984.6		$	(73.2	)	$	(1,279.4	)	$	1,502.8		$	1.1	$	869.7	$	1,984.6		$	(73.2	)	$	(1,279.4	)	$	1,502.8


																									Accumulated
																				Additional					Other						Total
																				Paid-In		Retained			Comprehensive			Treasury			Stockholders’
(In millions)																		Par		Capital		Earnings			Loss			Stock			Equity
Balance, December 31, 2021																		$	1.1	$	878.6	$	2,012.5		$	(126.5	)	$	(1,280.2	)	$	1,485.5
Net income	—		—				9.0		—			—				9.0		—		—			17.8		—			—				17.8
Change in other comprehensive income (loss)– net of tax	—		—			—				(20.6	)	—				(20.6	)
Dividends on common stock ($0.10 per share)																		—		—			(8.5	)	—			—				(8.5	)
Change in other comprehensive (loss) – net of tax																		—		—		—				(17.6	)	—				(17.6	)
Stock based compensation	—			3.7		—				-			(0.6	)		3.1		—			11.3	—			—				(1.4	)		9.9
Balance, September 30, 2021	$	1.1	$	873.4		$	1,993.6		$	(93.8	)	$	(1,280.0	)	$	1,494.3
Balance, March 31, 2022																		$	1.1	$	889.9	$	2,021.8		$	(144.1	)	$	(1,281.6	)	$	1,487.1
Net income																		—		—			44.7		—			—				44.7
Dividends on common stock ($0.10 per share)																		—		—			(8.5	)	—			—				(8.5	)
Change in other comprehensive (loss) – net of tax																		—		—		—				(47.2	)	—				(47.2	)
Stock based compensation																		—			4.2	—			—			—				4.2
Balance, June 30, 2022																		$	1.1	$	894.1	$	2,058.0		$	(191.3	)	$	(1,281.6	)	$	1,480.3

The accompanying notes are an integral part of these condensed consolidated financial statements.

Note 1 — Significant Accounting Policies

In these notes, the terms “Hexcel,” “the Company,” “we,” “us,” or “our” mean Hexcel Corporation and subsidiary companies. The accompanying condensed consolidated financial statements are those of Hexcel Corporation. Refer to Note 1 to the consolidated financial statements included in the Annual Report on Form 10-K for the year ended December 31, ~~2020~~2021 for a discussion of our significant accounting policies.

Basis of Presentation

The accompanying condensed consolidated financial statements have been prepared from the unaudited accounting records of Hexcel pursuant to rules and regulations of the Securities and Exchange Commission (“SEC”) and in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information. Certain information and footnote disclosures normally included in financial statements have been omitted pursuant to rules and regulations of the SEC. In the opinion of management, the condensed consolidated financial statements include all normal recurring adjustments as well as any non-recurring adjustments necessary to present fairly the statement of financial position, results of operations, cash flows and statement of stockholders’ equity for the interim periods presented. The Condensed Consolidated Balance Sheet as of December 31, ~~2020~~2021 was derived from the audited ~~2020~~2021 consolidated balance sheet. Interim results are not necessarily indicative of results expected for any other interim period or for the full year. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in our ~~2020~~2021 Annual Report on Form 10-K.

Investments in Affiliated Companies

We have a 50% equity investment in Aerospace Composites Malaysia Sdn. Bhd. ~~and a~~ 25~~% equity~~This investment ~~in HexCut Services SAS. These investments are~~is accounted for using the equity method of accounting.

Assets Held for Sale

In ~~early~~ November 2020 we closed our wind energy ~~prepeg~~prepreg production facility in Windsor, Colorado and as a result, certain plant assets to be sold with a carrying value of approximately $12.6 million have been recorded in “Assets held for sale” in the Condensed Consolidated Balance Sheets ~~at both September~~as of June 30, ~~2021~~2022 and December 31, ~~2020.~~2021. The sale of these assets is expected to occur during 2022.

During the first quarter of 2022, we entered into an agreement to sell our Dublin, California facility. The sale of the facility closed during the second quarter of 2022, and we received approximately $21.2 million in net proceeds from the sale and recorded a gain on the sale of approximately $19.4 million which is included in other operating (income) expense in the ~~fourth quarter~~Condensed Consolidated Statement of ~~2021.~~

~~Recently Adopted Accounting Pronouncements~~Operations. As a result of the sale of the building, the Company will be relocating certain of its Dublin-based research, technology and laboratory support personnel and equipment to a newly constructed facility in Salt Lake City, Utah.

~~In August 2018, the Financial Accounting Standards Board (“FASB”) issued~~ ~~Accounting Standards Update~~ ~~No. 2018-14 (ASU 2018-14), Compensation—Retirement Benefits—Defined Benefit Plans—General (Subtopic 715-20), which amends the current disclosure requirements regarding defined benefit pensions and other post retirement plans~~, ~~and allows for the removal of certain disclosures, while adding certain new disclosure requirements. This standard is effective for fiscal years beginning after December 15, 2020.~~ ~~Adoption of this new standard~~ ~~did not have a significant impact to our disclosures.~~

~~In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes,~~ ~~which amends and aims to simplify~~ ~~accounting disclosure~~ requirements regarding a number of topics including intraperiod tax allocation, accounting for deferred taxes when there are changes in consolidation of certain investments, tax basis step up in an acquisition and the application of effective rate changes during interim periods, among other improvements. This standard is effective for fiscal years beginning after December 15, 2020. Adoption of this new standard did not have a material impact on the Company.

Note 2 — Net Income (Loss) Per Common Share


	Quarter Ended September 30,				Nine Months Ended September 30,					Quarter Ended June 30,				Six Months Ended June 30,
(In millions, except per share data)	2021		2020		2021			2020		2022		2021		2022		2021
Basic net income (loss) per common share:
Net income (loss)	$	9.0	$	9.7	$	(2.8	)	$	51.1	$	44.7	$	2.2	$	62.5	$	(11.8	)
Weighted average common shares outstanding		84.1		83.8		84.1			83.7		84.4		84.1		84.3		84.0

Basic net income (loss) per common share	$	0.11	$	0.12	$	(0.03	)	$	0.61	$	0.53	$	0.03	$	0.74	$	(0.14	)

Diluted net income (loss) per common share:
Net income (loss)		9.0		9.7		(2.8	)		51.1	$	44.7	$	2.2		62.5		(11.8	)

Weighted average common shares outstanding — Basic		84.1		83.8		84.1			83.7		84.4		84.1		84.3		84.0
Plus incremental shares from assumed conversions:
Restricted stock units		0.3		0.1		0			0.2		0.4		0.3		0.4		0
Stock options		0.3		0.1		0			0.1		0.2		0.3		0.2		0
Weighted average common shares outstanding — Dilutive		84.7		84.0		84.1			84.0		85.0		84.7		84.9		84.0

Diluted net income (loss) per common share	$	0.11	$	0.12	$	(0.03	)	$	0.61	$	0.53	$	0.03	$	0.74	$	(0.14	)

Total common stock equivalents of 0.6 million and ~~1.5~~0.7 million were excluded from the computation of diluted net income (loss) per share for the quarter ended ~~September~~June 30, ~~2021~~2022 and ~~2020~~2021, respectively, because to do so would have been anti-dilutive. Total common stock equivalents of of0.7 million and 1.1 million ~~and~~were ~~0.9~~ ~~million were~~ excluded from the computation of diluted net income (loss) per share for the ~~nine~~six months ended ~~September~~June 30, 2022 and 2021, ~~and 2020,~~ respectively, because to do so would have been anti-dilutive.

Note 3 — Inventories



(In millions)	June 30, 2022		December 31, 2021
Raw materials	$	133.8	$	113.7
Work in progress		38.2		41.0
Finished goods		99.5		91.0
Total Inventory	$	271.5	$	245.7

(In millions)

September 30, 2021

December 31, 2020

Raw materials

$
112.0

$
94.9

Work in progress

37.6

23.6

Finished goods

94.9

95.0

Total Inventory

$
244.5

$
213.5

Note 4 — Retirement and Other Postretirement Benefit Plans

We maintain qualified and nonqualified defined benefit retirement plans covering certain current and former U.S. and European employees, retirement savings plans covering eligible U.S. and U.K. employees and certain postretirement health care and life insurance benefit plans covering eligible U.S. retirees. We also participate in a union sponsored multi-employer pension plan covering certain U.S. employees with union affiliations.

Defined Benefit Retirement Plans

Net Periodic Benefit Costs

Net periodic benefit costs of our defined benefit retirement plans for the ~~quarter~~three and ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020~~2021 were as follows:


	Quarter Ended September 30,				Nine Months Ended September 30,				Quarter Ended June 30,				Six Months Ended June 30,
(In millions)	2021		2020		2021		2020		2022		2021		2022		2021
U.S. Nonqualified Defined Benefit Retirement Plans
Service cost	$	0.2	$	0.3	$	0.8	$	0.9	$	0.3	$	0.3	$	0.6	$	0.5
Interest cost		0		0.2		0.2		0.4		0.1	0			0.2		0.1
Net amortization		0.3		-		0.5		0.2		0.2		0.2		0.4		0.4
Net periodic benefit cost	$	0.5	$	0.5	$	1.5	$	1.5	$	0.6	$	0.5	$	1.2	$	1.0


(In millions)	June 30, 2022		December 31, 2021
Amounts recognized on the balance sheet for U.S. nonqualified defined benefit retirement plans:
Accrued liabilities	$	3.2	$	2.7
Other non-current liabilities		21.1		21.3
Total accrued benefit	$	24.3	$	24.0


	Quarter Ended June 30,						Six Months Ended June 30,
(In millions)	2022			2021			2022			2021
European Defined Benefit Retirement Plans
Service cost	$	0.2		$	0.3		$	0.4		$	0.5
Interest cost		0.5			0.6			1.1			1.1
Expected return on plan assets		(0.5	)		(0.9	)		(1.1	)		(1.8	)
Net amortization and deferral		0.6			0.2			1.2			0.5
Net periodic benefit cost	$	0.8		$	0.2		$	1.6		$	0.3

(In millions)

September 30, 2021

December 31, 2020

Amounts recognized on the balance sheet for U.S. nonqualified defined benefit retirement plans:

Accrued liabilities

$
3.7

$
3.8

Other non-current liabilities

19.9

19.4

Total accrued benefit

$
23.6

$
23.2

Quarter Ended September 30,

Nine Months Ended September 30,

(In millions)

2021

2020

2021

2020

European Defined Benefit Retirement Plans

Service cost

$
0.2

$
0.2

$
0.7

$
0.7

Interest cost

0.5

0.9

1.6

2.6

Expected return on plan assets

(0.8
)

(1.7
)

(2.6
)

(5.1
)
Net amortization and deferral

0.3

0.1

0.8

0.3

Net periodic benefit cost (credit)

$
0.2

$
(0.5
)

$
0.5

$
(1.5
)


(In millions)	September 30, 2021		December 31, 2020		June 30, 2022		December 31, 2021
Amounts recognized on the balance sheet for European defined benefit retirement plans:
Other assets	$	35.0	$	31.5	$	6.6	$	6.9

Accrued liabilities		1.0		0.9		1.2		0.2
Other non-current liabilities		18.8		17.7		16.1		15.8
Total accrued benefit	$	19.8	$	18.6	$	17.3	$	16.0

All costs related to our pensions are included as a component of operating income in our Condensed Consolidated Statements of Operations. For the ~~quarters~~quarter ended ~~September~~June 30, ~~2021~~2022 and ~~2020,~~2021, amounts unrelated to service costs were a charge of $~~0.3~~0.9 million and ~~a benefit of~~ $~~0.5~~0.1 million, respectively. For the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020,~~2021, amounts unrelated to service costs were a charge of $~~0.6~~1.9 million and ~~a benefit of~~ $~~1.6~~0.3 million, respectively.

Contributions

We generally fund our U.S. non-qualified defined benefit retirement plans when benefit payments are incurred. We contributed approximately $~~0.5~~0.3 million in the first ~~nine~~six months of ~~2021~~2022 to cover unfunded benefits. We expect to contribute a total of $~~0.7~~3.2 million in ~~2021~~2022 to cover unfunded benefits. ~~We contributed $0.5~~ ~~million to our U.S. non-qualified defined benefit retirement plans during the first nine months of 2020.~~

We contributed $~~2.2~~0.3 million and $~~1.9~~2.2 million to our European defined benefit retirement plans during the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020~~2021, respectively. We plan to contribute approximately $~~5.6~~0.5 million during ~~2021~~2022 to our European plans.

Postretirement Health Care and Life Insurance Benefit Plans

We recorded $~~0.2~~0.5 million and $~~0.3~~0.2 million of net amortization gain deferral for the ~~quarters ended September 30, 2021 and 2020, respectively, and $0.6~~ ~~million and $0.7~~ ~~million for the nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020,~~2021, respectively. Net periodic benefit costs of our postretirement health care and life insurance benefit plans for the ~~quarters and nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020~~2021 were immaterial.


(In millions)	September 30, 2021		December 31, 2020		June 30, 2022		December 31, 2021
Amounts recognized on the balance sheet:
Accrued liabilities	$	0.4	$	0.4	$	0.3	$	0.3
Other non-current liabilities	2.2			2.2	1.5			1.5
Total accrued benefit	$	2.6	$	2.6	$	1.8	$	1.8

Amounts contributed in connection with our postretirement plans were immaterial for both the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020.~~2021. We periodically fund our postretirement plans to pay covered expenses as they are incurred. We expect to contribute less than $~~0.4~~0.3 million in ~~2021~~2022 to cover unfunded benefits.

Note 5 –– Debt


(In millions)	September 30, 2021			December 31, 2020			June 30, 2022			December 31, 2021
Current portion of finance lease	$	0.9		$	0.9		$	0.5		$	0.9
Current portion of debt		0.9			0.9			0.5			0.9
Senior unsecured credit facility		179.0			228.0			114.0			125.0
4.7% senior notes --- due 2025		300.0			300.0			300.0			300.0
3.95% senior notes --- due 2027		400.0			400.0			400.0			400.0
Senior notes --- original issue discount		(1.3	)		(1.5	)		(1.1	)		(1.2	)
Senior notes --- deferred financing costs		(3.0	)		(3.5	)		(2.5	)		(2.9	)
Non-current portion of finance lease and other debt		1.7			2.5			1.6			1.5
Long-term debt		876.4			925.5			812.0			822.4
Total debt	$	877.3		$	926.4		$	812.5		$	823.3

In June 2019, the Company refinanced its senior unsecured credit facility (the “Facility”), increasing borrowing capacity from $700 million to $1 billion. The Facility matures in June 2024. The interest rate ranges from LIBOR + 0.875% to a maximum of LIBOR + 1.50%, depending upon the better of the Company’s leverage ratio or the credit rating. The Facility agreement contains

financial and other covenants, including, but not limited to customary restrictions on the incurrence of debt by our subsidiaries and the granting of liens, as well as the maintenance of an interest coverage ratio and a leverage ratio.

In September 2020, we amended the Facility to allow for relief from certain terms, including adjusting the maximum leverage ratio covenant for a defined period. On January 28, 2021, we further amended the Facility agreement (the “Second Amendment”) to provide that, from January 28, 2021 through and including March 31, 2022, we ~~will~~would not be subject to a maximum leverage ratio covenant but ~~will~~ instead be required to maintain Liquidity (as defined in the Facility agreement) of at least $250 million. Additionally, during such period, the Company ~~will be~~was subject to limitations on share repurchases, cash dividends, and its ability to incur secured debt, in each case subject to certain exceptions; the applicable margin and commitment fees ~~are~~would be increased; the incremental facility ~~will~~would not be available; and if the Company’s public debt rating iswas downgraded to (i) BB or lower by Standard & Poor’s and (ii) Ba2 or lower by Moody’s, we ~~will~~would be required to grant liens on certain of our assets, which liens ~~will~~would be released upon the Company’s public debt rating being upgraded to BB+ or higher by Standard & Poor’s or Ba1 or higher by Moody’s. The Company’s public debt rating as of ~~September~~June 30, ~~2021~~2022 is BB+/Baa3. In addition, the Second Amendment ~~provides~~provided that the Company ~~will~~would not be subject to an interest coverage ratio covenant until the test period ending December 31, 2021 and revolving commitments under the Facility were reduced from $1 billion to $750 million. ~~In connection with the Second Amendment, we accelerated a portion of the deferred financing costs and recognized $0.9~~ ~~million in interest expense during the first quarter of 2021.~~ As of ~~September~~June 30, ~~2021,~~2022, we were in compliance with all debt covenants. As of April 1, 2022, the original terms and conditions to the Facility agreement were reinstated except that the amount of the lender's commitment will remain at $750 million. Share repurchases restrictions that had been in effect per the Second Amendment expired on March 31, 2022.

As of ~~September~~June 30, ~~2021,~~2022, total borrowings under the Facility were $~~179~~114 million, which approximates fair value. The Facility agreement permits us to issue letters of credit up to an aggregate amount of $50 million. Outstanding letters of credit reduce the amount available for borrowing under the Facility. As of ~~September~~June 30, ~~2021,~~2022, there were 0 issued letters of credit under the Facility, resulting in undrawn availability under the Facility of $~~571~~636 million. The weighted average interest rate for the Facility was ~~4.16~~4.2% for the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022.

In 2017, the Company issued $400 million in aggregate principal amount of 3.95% Senior Unsecured Notes due in 2027. The interest rate on these senior notes may be increased 0.25% each time a credit rating applicable to the notes is downgraded. Conversely, such increases would be reversed should the credit rating be subsequently upgraded. The maximum rate is 5.95%. The effective interest rate for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 was ~~4.08~~4.11% inclusive of an approximately 0.25% benefit of treasury locks. Based on quoted prices the fair value of the senior unsecured notes due in 2027 was $~~437.4~~375.6 million at ~~September~~June 30, ~~2021.~~2022.

In 2015, the Company issued $300 million in aggregate principal amount of 4.7% Senior Unsecured Notes due in 2025. The interest rate on these senior notes may be increased by 0.25% each time a credit rating applicable to the notes is downgraded. Conversely, such increases would be reversed should the credit rating be subsequently upgraded. The maximum rate is 6.7%. The effective interest rate for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 was ~~5.03~~5.07%. Based on quoted prices, the fair value of the senior unsecured notes due in 2025 was $~~331.9~~293.9 million at ~~September~~June 30, ~~2021.~~2022.

Note 6 — Derivative Financial Instruments

Interest Rate Swap and Interest Lock Agreements

At ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, we had 0 interest rate swap agreements outstanding.

The Company had treasury lock agreements to protect against unfavorable movements in the benchmark treasury rate related to the issuance of our 3.95% Senior Unsecured Notes. These hedges were designated as cash flow hedges for hedge accounting purposes thus any change in fair value was recorded as a component of other comprehensive (loss) income. As part of the issuance of our 3.95% Senior Unsecured Notes, we net settled these derivatives for $10 million in cash. As a result of settling these derivatives the previously deferred gains recorded in other comprehensive (loss) income will be released to interest expense over the life of the 3.95% Senior Unsecured Notes. The effect of these treasury locks reduced the effective interest rate on these notes by approximately 0.25%.

Cross Currency and Interest Rate Swap Agreements

In November 2020, we entered into a cross currency and interest rate swap, which is designated as a cash flow hedge of a €270 million, 5-year amortizing, intercompany loan between one of our European subsidiaries and the U.S. parent company. Changes in the spot exchange are recorded to the general ledger and offset the fair value re-measurement of the hedged item. The net difference in the interest rates coupons is recorded as a credit to interest expense. The derivative swaps €270 million bearing interest at a fixed rate of 0.30% for $319.9 million plus fixed rate interest of 1.115%. The interest coupons settle semi-annually. The principal will amortize each year on November 15, as follows: for years 1 through 4, beginning November 15, 2021, €50 million versus $59.2 million, and a final settlement on November 15, 2025 of €70 million versus $82.9 million. The carrying value of the derivative at ~~September~~June 30, ~~2021~~2022 is a

current asset of $~~3.2~~8.1 million and a long-term asset of $~~2.1~~15.8 million. The carrying value of the derivative at December 31, 2021 was a current asset of $4.0 million and a long-term asset of $3.4 million.

Foreign Currency Forward Exchange Contracts

A number of our European subsidiaries are exposed to the impact of exchange rate volatility between the U.S. dollar and the subsidiaries’ functional currencies, being either the Euro or the British pound sterling. We have entered into contracts to exchange U.S. dollars for Euros and British pound sterling through ~~March~~December 2024. The aggregate notional amount of these contracts was $~~250.5~~434.5 million and $~~250.3~~316.4 million at ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, respectively. The purpose of these contracts is to hedge a portion of the forecasted transactions of our European subsidiaries under long-term sales contracts with certain customers. These contracts are expected to provide us with a more balanced matching of future cash receipts and expenditures by currency, thereby reducing our exposure to fluctuations in currency exchange rates. The effective portion of the hedges, losses of $~~6.2~~21.6 million and $~~10.2~~28.4 million were recorded in other comprehensive (loss) income for the quarter and ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, respectively, and gainsof $~~14.4~~1.5 million and losses of $~~0.1~~3.9 million were recorded for the quarter and ~~nine~~six months ended ~~September~~June 30, ~~2020,~~2021, respectively. We classified $~~3.2~~0.2 million of the carrying amount of these contracts as assets ($($~~3.1~~0.1 million of which was recorded in prepaid expenses and other current assets) and $~~4.8~~29.2 million as liabilities ($~~2.2~~10.8 million of which is recorded in non-current liabilities) on the Condensed Consolidated Balance Sheets at ~~September~~June 30, ~~2021,~~ 2022, and $~~16.0~~1.9 million of the carrying amount of these contracts was classified in assets ($~~10.7~~1.7 million of which was recorded in prepaid expenses and other current assets) and $~~2.5~~6.8 million as liabilities (less than $~~0.1~~3.9 million of which is in other non-current liabilities) at December 31, ~~2020.~~2021. We recognized ~~net gains~~losses of $~~1.5~~3.6 million and $~~4.8~~4.3 million in gross margin during the quarter and ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, respectively, and ~~net losses~~gains of $~~2.6~~1.9 million and $~~12.7~~3.3 million for the quarter and ~~nine~~six months ended ~~September~~June 30, ~~2020,~~2021, respectively.

In addition, we enter into foreign exchange forward contracts which are not designated as hedges. These are used to provide an offset to transactional gains or losses arising from the remeasurement of non-functional monetary assets and liabilities such as accounts receivable. The change in the fair value of the derivatives is recorded in the statement of operations. There are 0 credit contingency features in these derivatives. During the quarter and ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, we recognized net foreign exchange lossesof $~~0.3~~0.8 million and $~~1.4~~1.0 million, respectively, in the Condensed Consolidated Statements of Operations. During the quarter and ~~nine~~six months ended ~~September~~June 30, ~~2020,~~2021, we recognized net foreign exchange gains of $0.5 million and losses of $~~0.9~~ ~~million and $2.5~~1.1 million, respectively. The net foreign exchange impact recognized from these hedges offset the translation exposure of these transactions.The carrying amount of the contracts for derivatives not designated as hedging instruments was $~~0.1~~0.2 million classified in current ~~liabilities~~assets at ~~September~~June 30, ~~2021,~~2022, and $~~0.1~~0.2 million classified in current liabilities on our Condensed Consolidated Balance Sheet at December 31, ~~2020.~~2021.

The change in fair value of our foreign currency forward exchange contracts under hedge designations recorded net of tax within accumulated other comprehensive (loss) income for the quarters and ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~September~~June 30, ~~2020~~2021 was as follows:

Quarter Ended September 30,

Nine Months Ended September 30,

(In millions)

2021

2020

2021

2020

Unrealized gains (losses) at beginning of period, net of tax

$
5.3

$
(12.3
)

$
10.6

$
(8.4
)
(Gains) losses reclassified to net sales

(1.2
)

2.0

(3.7
)

9.7

(Decrease) increase in fair value

(4.8
)

11.1

(7.6
)

(0.5
)
Unrealized (losses) gains at end of period, net of tax

$
(0.7
)

$
0.8

$
(0.7
)

$
0.8


	Quarter Ended June 30,						Six Months Ended June 30,
(In millions)	2022			2021			2022			2021
Unrealized (losses) gains at beginning of period, net of tax	$	(8.0	)	$	5.6		$	(3.5	)	$	10.6
Losses (gains) reclassified to net sales		2.8			(1.5	)		3.1			(2.5	)
Decrease in fair value		(16.5	)		1.2			(21.3	)		(2.8	)
Unrealized (losses) gains at end of period, net of tax	$	(21.7	)	$	5.3		$	(21.7	)	$	5.3

Unrealized gains of $~~0.9~~18.4 million recorded in accumulated other comprehensive loss, less taxes of $~~0.1~~4.4 million, as of ~~September~~June 30, ~~2021,~~2022, are expected to be reclassified into earnings over the next twelve months as the hedged sales are recorded.

Commodity Swap Agreements

On occasion we enter into commodity swap agreements to hedge against price fluctuations of raw materials, including propylene (the principal component of acrylonitrile). As of ~~September~~June 30, ~~2021,~~2022, we had commodity swap agreements with a notional value of $~~12.2~~23.4 million. The swaps mature monthly through June ~~2023.~~2024. The swaps are accounted for as a cash flow hedge of our forward raw material purchases. To ensure the swaps are highly effective, all of the critical terms of the swap matched the terms of the hedged items. The fair value of the commodity swap agreements was an asset of $~~4.6~~0.2 million ($~~4.2~~0.2 million of which was recorded in prepaid expenses and other current assets) and a liability of ~~less than~~ $~~0.1~~3.1 million ~~at September 30, 2021. The fair value of the commodity swap agreements was~~($0.9 million of which was recorded in other non-current liabilities) at June 30, 2022, and an asset of $~~2.2~~0.9 million ($~~1.5~~0.9 million of which was recorded in prepaid expenses and other current assets) and a liability of $~~1.1~~2.3 million ~~at December 31, 2020.~~

~~Note 7 — Income Taxes~~

~~The effective tax rate for the quarter ended September 30, 2021 was~~ ~~38.3% and included a discrete tax charge of $1.3~~ ~~million primarily related to the remeasurement of the net state deferred tax liabilities. The tax expense for the nine months ended September 30, 2021 was $1.6~~ ~~million and included a net discrete tax charge of $~~($0.8 million ~~primarily resulting from the revaluation~~ of ~~U.S. and foreign deferred tax liabilities. The tax benefit for the quarter ended September 30, 2020~~which was $~~56.9~~recorded in other non-current liabilities) at December 31, 2021. ~~million and included a $46.2~~ ~~million benefit primarily due to the release of a valuation allowance in a foreign jurisdiction due to a legal entity rationalization and treasury realignment initiative. The tax benefit of $48.7~~ ~~million for the first nine months of 2020 also included a $2.7~~ ~~million benefit primarily for the release of reserves of unrecognized tax benefits as a result of tax audit settlements.~~

Note 87 — Fair Value Measurements

The authoritative guidance for fair value measurements establishes a hierarchy for observable and unobservable inputs used to measure fair value, into three broad levels, which are described below:

•

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs.

•

Level 2: Observable prices that are based on inputs not quoted on active markets but corroborated by market data.

•

Level 3: Unobservable inputs are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs.

In determining fair value, we utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as consider our own and counterparty credit risk in our assessment of fair value.

We have 0 assets or liabilities that utilize Level 1 inputs. However, we have derivative instruments classified as liabilities and assets which utilize Level 2 inputs, and 1 liability that utilizes Level 3 inputs.

For derivative assets and liabilities that utilize Level 2 inputs, we prepare estimates of future cash flows of our derivatives, which are discounted to a net present value. The estimated cash flows and the discount factors used in the valuation model are based on observable inputs, and incorporate non-performance risk (the credit standing of the counterparty when the derivative is in a net asset position, and the credit standing of Hexcel when the derivative is in a net liability position). The fair value of these assets and liabilities was $~~13.1~~24.4 million and $~~4.8~~32.3 million, respectively, at ~~September~~June 30, ~~2021~~2022 and $~~18.4~~10.2 million and $~~14.8~~9.3 million, respectively,

at December 31, ~~2020.~~2021. In addition, the fair value of these derivative contracts, which are subject to a master netting arrangement under certain circumstances, is presented on a gross basis in the Condensed Consolidated Balance Sheets.

Below is a summary of valuation techniques for all Level 2 financial assets and liabilities:

•

Cross Currency and Interest Rate Swap Agreements — valued using the USD Secured Overnight Financing Rate curves and quoted forward foreign exchange prices at the reporting date. The fair value of the assets were $~~5.3~~23.9 million, at ~~September~~June 30, ~~2021~~2022 and the fair value of the assets ~~and liabilities~~ were $~~0.3~~7.4 million, ~~and $11.1~~ ~~million, respectively,~~ at December 31, ~~2020.~~2021.

•

Foreign exchange derivative assets and liabilities — valued using quoted forward foreign exchange prices at the reporting date. Fair value of assets and liabilities at ~~September~~June 30, ~~2021~~2022 was $~~3.2~~0.2 million and $~~4.8~~29.2 million, respectively. The fair value of assets and liabilities at December 31, ~~2020~~2021 was $~~16.0~~1.9 million and $~~2.6~~7.0 million, respectively.

•

Commodity swap agreements — valued using quoted forward commodity prices at the reporting date. Fair value of the assets and liabilities at ~~September~~June 30, ~~2021~~2022 was $~~4.6~~0.2 million and ~~less than~~ $~~0.1~~3.1 million, respectively. The fair value of the assets and liabilities at December 31, ~~2020~~2021 was $~~2.2~~0.9 million and $~~1.1~~2.3 million, respectively.

Counterparties to the above contracts are highly rated financial institutions, NaN of which experienced any significant downgrades in the ~~nine~~three months ended ~~September~~June 30, ~~2021~~2022 that would reduce the receivable amount owed, if any, to the Company.

Liabilities classified as Level 3 — At ~~September~~June 30, ~~2021~~2022 we had a liability for $0.4 million, which represented contingent consideration that was recognized in connection with the Company’s Oxford Performance Materials, Inc. acquisition. This amount was estimated based on certain contractual stipulations which require payments to be made to the seller in the future based upon the achievement of certain results. We used forecasted results which were discounted using an internally derived discount rate. Future amounts payable may differ from this estimate by the difference between the actual and forecasted results.

Note 98 — Revenue

Our revenue is primarily derived from the sale of inventory under long-term contracts with our customers. We have determined that individual purchase orders (“PO”), the terms and conditions of which are taken with a master agreement, create the ASC 606 contracts which are generally short-term in nature. For those sales that are not tied to a long-term agreement, we generate a PO that is subject to our standard terms and conditions. In instances where our customers acquire our goods related to government contracts, the contracts are typically subject to terms similar, or equal to, the Federal Acquisition Regulation Part 52.249-2. This regulation contains a termination for convenience clause (“T for C”), which requires that the customer pay for the cost of both the finished and unfinished goods at the time of cancellation plus a reasonable profit.

We recognize revenue over time for those agreements that have T for C, and where the products being produced have no alternative use. As our production cycle is typically nine months or less, it is expected that goods related to the revenue recognized

over time will be shipped and billed within the next twelve months. Less than half of our agreements contain provisions which would require revenue to be recognized over time. All other revenue is recognized at a point in time.

We disaggregate our revenue based on market for analytical purposes. The following table details our revenue by market for the quarters and ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020:~~2021:


	Quarter Ended September 30,				Nine Months Ended September 30,				Quarter Ended June 30,				Six Months Ended June 30,
(In millions)	2021		2020		2021		2020		2022		2021		2022		2021
Consolidated Net Sales	$	333.8	$	286.9	$	964.4	$	1,206.6	$	393.0	$	320.3	$	783.6	$	630.6
Commercial Aerospace		167.2		128.8		468.5		695.6		227.6		153.7		446.5		301.3
Space & Defense		110.4		108.8		329.0		328.8		111.9		106.9		230.1		218.6
Industrial		56.2		49.3		166.9		182.2		53.5		59.7		107.0		110.7

Revenue recognized over time gives rise to contract assets, which represent revenue recognized but unbilled. Contract assets are included in our Condensed Consolidated Balance Sheets as a component of current assets. The activity related to contract assets for the ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 was as follows:


(In millions)	Composite Material			Engineered Products			Total			Composite Material		Engineered Products			Total
Balance at December 31, 2020	$	7.8		$	35.3		$	43.1
Balance at December 31, 2021										$	6.8	$	23.7		$	30.5
Net revenue billed		1.6			(2.4	)		(0.8	)		0.6		1.4			2.0
Balance at March 31, 2021	$	9.4		$	32.9		$	42.3
Balance at March 31, 2022											7.4		25.1			32.5
Net revenue billed		(1.8	)		—			(1.8	)	$	0.2	$	(2.6	)		(2.4	)
Balance at June 30, 2021	$	7.6		$	32.9		$	40.5
Net revenue billed		(0.3	)		(1.8	)		(2.1	)
Balance at September 30, 2021	$	7.3		$	31.1		$	38.4
Balance at June 30, 2022										$	7.6	$	22.5		$	30.1

Accounts receivable, net, includes amounts billed to customers where the right to payment is unconditional.

Note 109 — Segment Information

The financial results for our operating segments are prepared using a management approach, which is consistent with the basis and manner in which we internally segregate financial information for the purpose of assisting in making internal operating decisions. We evaluate the performance of our operating segments based on operating income, and generally account for intersegment sales based on arm’s length prices. Corporate and certain other expenses are not allocated to the operating segments, except to the extent that the expense can be directly attributable to the business segment.

1413

Financial information for our operating segments for the quarters and ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020~~2021 were as follows:

(Unaudited)

Composite

Engineered

Corporate &

(In millions)

Materials

Products

Other (a)

Total

Third Quarter 2021

Net sales to external customers

$
254.1

$
79.7

$
—

$
333.8

Intersegment sales

15.0

0.4

(15.4
)

—

Total sales

$
269.1

$
80.1

$
(15.4
)

$
333.8

Other operating expense

0.8

0

0

0.8

Operating income (loss)

30.0

6.5

(13.7
)

22.8

Depreciation and amortization

30.1

3.6

0

33.7

Stock-based compensation

0.7

0.1

2.1

2.9

Accrual basis additions to capital expenditures

3.7

2.8

0

6.5

Third Quarter 2020

Net sales to external customers

$
215.7

$
71.2

$
—

$
286.9

Intersegment sales

7.8

0.7

(8.5
)

—

Total sales

$
223.5

$
71.9

$
(8.5
)

$
286.9

Other operating expense

16.4

—

(0.6
)

15.8

Operating (loss) income

(36.6
)

(2.7
)

1.7

(37.6
)
Depreciation and amortization

31.7

3.9

—

35.6

Stock-based compensation

1.5

0.5

(1.7
)

0.3

Accrual basis additions to capital expenditures

4.7

1.3

—

6.0

Nine Months Ended September 30, 2021

Net sales to external customers

$
732.2

$
232.2

$
—

$
964.4

Intersegment sales

42.8

1.8

(44.6
)

—

Total sales

$
775.0

$
234.0

$
(44.6
)

$
964.4

Other operating expense

16.3

(0.5
)

0.2

16.0

Operating income (loss)

61.9

17.1

(50.2
)

28.8

Depreciation and amortization

91.4

10.9

0.1

102.4

Stock-based compensation

2.1

0.4

13.7

16.2

Accrual basis additions to capital expenditures

10.7

3.6

—

14.3

Nine Months Ended September 30, 2020

Net sales to external customers

$
960.4

$
246.2

$
—

$
1,206.6

Intersegment sales

48.0

1.6

(49.6
)

—

Total sales

$
1,008.4

$
247.8

$
(49.6
)

$
1,206.6

Other operating expense

25.5

2.7

15.4

43.6

Operating income (loss)

75.0

3.3

(43.8
)

34.5

Depreciation and amortization

94.3

11.6

0.1

106.0

Stock-based compensation

5.9

1.6

5.5

13.0

Accrual basis additions to capital expenditures

35.4

4.0

—

39.4


	(Unaudited)
	Composite		Engineered			Corporate &
(In millions)	Materials		Products			Other (a)			Total
Quarter Ended June 30, 2022
Net sales to external customers	$	318.1	$	74.9		$	—		$	393.0
Intersegment sales		18.5		1.0			(19.5	)		—
Total sales	$	336.6	$	75.9		$	(19.5	)	$	393.0
Other operating (income) expense		0.3		0			(19.4	)		(19.1	)
Operating income		47.2		9.1			7.5			63.8
Depreciation and amortization		28.1		3.5			0.1			31.7
Stock-based compensation		0.9		0.3			1.2			2.4
Accrual basis additions to capital expenditures		14.5		2.7			0			17.2

Quarter Ended June 30, 2021
Net sales to external customers	$	240.9	$	79.4		$	—		$	320.3
Intersegment sales		14.6		0.8			(15.4	)		—
Total sales	$	255.5	$	80.2		$	(15.4	)	$	320.3
Other operating (income) expense		2.8		0.2			0.1			3.1
Operating income		24.5		5.9			(14.2	)		16.2
Depreciation and amortization		30.5		3.6			0.1			34.2
Stock-based compensation		0.8		0.1			3.4			4.3
Accrual basis additions to capital expenditures		3.4		0.4			0			3.8

Six Months Ended June 30, 2022
Net sales to external customers	$	631.9	$	151.7		$	—		$	783.6
Intersegment sales		35.0		1.3			(36.3	)		—
Total sales	$	666.9	$	153.0		$	(36.3	)	$	783.6
Other operating (income) expense		1.2		0.1			(19.4	)		(18.1	)
Operating income		89.8		19.7			(15.6	)		93.9
Depreciation and amortization		56.7		7.1			0.1			63.9
Stock-based compensation		3.5		1.0			8.3			12.8
Accrual basis additions to capital expenditures		24.6		3.7			0			28.3

Six Months Ended June 30, 2021
Net sales to external customers	$	478.1	$	152.5		$	—		$	630.6
Intersegment sales		27.8		1.4			(29.2	)		—
Total sales	$	505.9	$	153.9		$	(29.2	)	$	630.6
Other operating (income) expense		15.5		(0.5	)		0.2			15.2
Operating income		31.9		10.6			(36.5	)		6.0
Depreciation and amortization		61.3		7.3			0.1			68.7
Stock-based compensation		1.4		0.3			11.6			13.3
Accrual basis additions to capital expenditures		7.0		0.8			0			7.8

(a)

We do not allocate corporate expenses to the operating segments.


Goodwill and Intangible Assets	Composite			Engineered						Composite			Engineered
(In millions)	Materials			Products			Total			Materials			Products			Total
Balance at December 31, 2020	$	98.7		$	179.1		$	277.8
Balance at December 31, 2021										$	93.4		$	174.1		$	267.5
Amortization expense		(1.5	)		(3.8	)		(5.3	)		(0.5	)		(1.3	)		(1.8	)
Currency translation adjustments		(2.7	)		0.1			(2.6	)		(5.7	)		(1.2	)		(6.9	)
Balance at September 30, 2021	$	94.5		$	175.4		$	269.9
Balance at June 30, 2022										$	87.2		$	171.6		$	258.8

At ~~September~~June 30, ~~2021,~~2022, the balance of goodwill and intangible assets was $~~191.1~~186.5 million and $~~78.8~~72.3 million, respectively.

The ~~amounts~~amount of net (gains) losses reclassified to earnings from the unrecognized net defined benefit and postretirement plan costs ~~component~~and derivative products components of accumulated other comprehensive ~~loss~~income (loss) for the quarter and ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, were ~~less than $~~as follows:


	Quarter Ended June 30, 2022						Six Months Ended June 30, 2022
(In millions)	Pre-tax (gain) loss			Net of tax (gain) loss			Pre-tax (gain) loss			Net of tax (gain) loss
Defined Benefit and Postretirement Plan Costs	$	0.6		$	0.5		$	1.1		$	0.8

Derivative Products
Foreign currency forward exchange contracts		3.6			2.7			4.3			3.1
Commodity swaps		(0.3	)		(0.2	)		(1.1	)		(0.8	)
Interest rate swaps		2.5			1.9			(5.0	)		(3.9	)
Total Derivative Products	$	5.8		$	4.4		$	(1.8	)	$	(1.6	)

Note 11 — ~~0.3~~Commit ~~million less taxes of less than $0.1~~ ~~million~~ments and $Contingencies ~~0.5~~ ~~million less taxes of less than $0.1~~ million, respectively. The amounts reclassified to earnings from the change in fair value of the derivatives products component of accumulated other comprehensive loss for the quarter and nine months ended September 30, 2021 were net gains of $~~1.5~~ ~~million less taxes of $0.3~~ ~~million and $4.8~~ ~~million less taxes of $1.1~~ ~~million, respectively, for those related to foreign currency forward exchange contracts and gains of $2.0~~ ~~million less taxes of $0.5~~ ~~million and $2.8~~ ~~million less taxes of $0.7~~ ~~million, respectively, related to commodity swaps. We also recorded net losses of $3.8~~ ~~million less taxes of $0.9~~ ~~million and net gains of $6.5~~ ~~million less taxes of less than $1.5~~ ~~million related to interest rate derivatives, for the three- and nine-month periods ended September 30, 2021, respectively.~~

~~Note 12 — Commitments and Contingencies~~

We are involved in litigation, investigations and claims arising out of the normal conduct of our business, including those relating to commercial transactions, environmental, employment and health and safety matters. While it is impossible to predict the ultimate resolution of litigation, investigations and claims asserted against us, we believe, based upon our examination of currently available information, our experience to date, and advice from legal counsel, that, after taking into account our existing insurance coverage and amounts already provided for, the currently pending legal proceedings against us will not have a material adverse impact on our consolidated results of operations, financial position or cash flows.

Environmental Matters

We have been named as a potentially responsible party (“PRP”) with respect to the below and other hazardous waste disposal sites that we do not own or possess, which are included on, or proposed to be included on, the Superfund National Priority List of the U.S. Environmental Protection Agency (“EPA”) or on equivalent lists of various state governments. Because the Federal Comprehensive Environmental Response, Compensation and Liability Act (“CERCLA” or “Superfund”) allows for joint and several liability in certain circumstances, we could be responsible for all remediation costs at such sites, even if we are one of many PRPs. We believe, based on the amount and nature of ~~our~~the hazardous waste at issue, and the number of other financially viable PRPs at each site, that our liability in connection with such environmental matters will not be material.

Lower Passaic River Study Area

Hexcel together with approximately 48 other PRPs that comprise the Lower Passaic Cooperating Parties Group (the “CPG”), are subject to a May 2007 Administrative Order on Consent (“AOC”) with the EPA requiring the CPG to perform a Remedial

Investigation/Feasibility Study of environmental conditions of a 17-mile stretch of the Passaic River in New Jersey (the “Lower Passaic River”). We were included in the CPG based on our operations at our former manufacturing site in Lodi, New Jersey.

In March 2016, the EPA issued a Record of Decision (“ROD”) setting forth the EPA’s selected remedy for the lower 8 miles of the Lower Passaic River at an expected cost ranging from $0.97 billion to $2.07 billion. This estimate ~~does~~did not include any costs related to a future remedy for the upper 9 miles of the Lower Passaic River. In August 2017, the EPA appointed an independent third-party allocation expert to make recommendations on the relative liability of approximately 120 identified non-government

~~PRPs.~~ PRPs for the lower eight miles of the Lower Passaic River. In December 2020, the allocator issued its non-binding report on PRP liability (including Hexcel’s) to the ~~EPA, which did not result in any change to Hexcel’s accrual for the Passaic matter.~~ ~~We do not know to what extent, if at all, this non-binding report will impact the ultimate outcome of the matter.~~ EPA. In October 2021, the EPA released a ROD selecting an interim remedy for the upper 9 miles of the Lower Passaic River at an expected additional cost ranging from $308.7 million to $661.5 million..

In October 2016, pursuant to a settlement agreement with the EPA, Occidental Chemical Corporation (“OCC”), one of the PRPs, commenced performance of the remedial design required by the ROD for the lower 8 miles of the Lower Passaic River, reserving its right of cost contribution from all other PRPs. In June 2018, OCC filed suit against approximately 120 parties, including Hexcel, in the U.S. District Court of the District of New Jersey seeking cost recovery and contribution under CERCLA related to the Lower Passaic River. In July 2019, the court granted in part and denied in part the defendants’ motion to dismiss. In August 2020, the court granted defendants’ motion for summary judgement for certain claims. Discovery for the remaining claims is ongoing. On February 24, 2021, Hexcel and certain other defendants filed a third-party complaint against the Passaic Valley Sewerage Commission and certain New Jersey municipalities seeking recovery of Passaic-related cleanup costs incurred by defendants, as well as contribution for any cleanup costs incurred by OCC for which the court deems the defendants liable.

~~The accrual related to the Lower Passaic River site was approximately $2.1~~ million as of September 30, 2021 and December 31, 2020. Given the uncertainty associated with the many elements of the Superfund process for the Lower Passaic River, the amounts accrued may not be indicative of the amounts for which we will ultimately be responsible.

Summary of Environmental Reserves

Our estimate of liability as a PRP and our remaining costs associated with our responsibility to remediate the Lower Passaic River and other sites are accrued in the Condensed Consolidated Balance Sheets. As of ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, our aggregate environmental related accruals were $~~2.2~~7.1 million and $~~2.4~~2.1 million, ~~respectively,~~respectively. These amounts are included in non-current liabilities with the exception of ~~which~~ $~~0.2~~0.1 million ~~and $0.5~~ ~~million, respectively,~~at December 31, 2021 which was included in accrued ~~liabilities with the remainder included in other non-current~~ liabilities. As related to certain environmental matters the accrual was estimated at the low end of a range of possible outcomes since 0 amount within the range is a better estimate than any other amount. ~~If we had accrued, for those sites where we are able to estimate our liability, at the high end of the range of possible outcomes, our accrual would have been $~~16 ~~million higher at September 30, 2021 and December 31, 2020.~~

These accruals can change significantly from period to period due to such factors as additional information on the nature or extent of contamination, the methods of remediation required, changes in the apportionment of costs among responsible parties and other actions by governmental agencies or private parties, or the impact, if any, of being named in a new matter.

Product Warranty

We provide standard assurance-type warranties for our products, which cannot be purchased separately and do not meet the criteria to be considered a performance obligation. Warranty expense for the ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, and accrued warranty cost, included in “accrued liabilities” in the Condensed Consolidated Balance Sheets at ~~September~~June 30, ~~2021~~2022 and December 31, ~~2020,~~2021, were as follows:


	Product			Product
(In millions)	Warranties			Warranties
Balance as of December 31, 2020	$	2.6
Balance as of December 31, 2021				$	2.5
Warranty expense		0.2			1.2
Deductions and other		(0.3	)		(0.5	)
Balance as of March 31, 2021	$	2.5
Balance as of March 31, 2022				$	3.2
Warranty expense		(0.5	)		0.5
Deductions and other		(0.2	)		(0.8	)
Balance as of June 30, 2021	$	1.8
Warranty expense		0.3
Deductions and other		(0.3	)
Balance as of September 30, 2021	$	1.8
Balance as of June 30, 2022				$	2.9

Note 1312 — ~~Other Operating Expense~~Restructuring

We recognized restructuring charges of $~~0.8~~0.3 million and $~~18.3~~1.1 million for the quarter and ~~nine~~six months ended ~~September~~June 30, ~~2021,~~2022, respectively, primarily related to ~~severance and asset impairments.~~severance. Anticipated future cash payments as of ~~September~~June 30, ~~2021~~2022 were $~~10.3~~2.8 million. ~~For the nine months ended September 30, 2021, other operating expenses also included a benefit related to the reduction of a contingent liability.~~


			Activity for the Quarter Ended June 30, 2022
	March 31,		Restructuring					Cash					June 30,
(In Millions)	2021		Charge		FX Impact			Paid			Non-Cash		2022
Employee termination	$	3.8	$	0.3	$	(0.1	)	$	(1.2	)	$	0	$	2.8
Impairment and other		0		0		0			0			0		—
Total	$	3.8	$	0.3	$	(0.1	)	$	(1.2	)	$	0	$	2.8


			Activity for the Six Months Ended June 30, 2022
	December 31,		Restructuring					Cash					June 30,
(In Millions)	2021		Charge		FX Impact			Paid			Non-Cash		2022
Employee termination	$	9.0	$	1.0	$	(0.3	)	$	(6.9	)	$	0	$	2.8
Impairment and other		0		0.1		0			(0.1	)		0		0
Total	$	9.0	$	1.1	$	(0.3	)	$	(7.0	)	$	0	$	2.8

~~For the quarter ended September 30, 2020, we recognized a restructuring charge of $15.8~~ ~~million, of which $9.4~~ million related to asset impairments for the planned closure of our Windsor, Colorado plant, and the remainder was primarily related to severance due to job reductions. For the nine months ended 2020, other operating expense of $~~43.6~~ ~~million primarily related to costs associated with the terminated merger agreement with Woodward, Inc. as well as restructuring charges related to job reductions.~~

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

We develop, manufacture, and market lightweight, high-performance structural materials, including carbon fibers, specialty reinforcements, prepregs and other fiber-reinforced matrix materials, honeycomb, adhesives, radio ~~frequency /~~ frequency/electromagnetic interference (“RF/EMI”) and microwave absorbing materials, engineered honeycomb and composite structures, for use in Commercial Aerospace, Space & Defense, and Industrial markets. ~~Our products~~We propel the future of flight, energy generation, transportation, and recreation through excellence in providing innovative high-performance material solutions that are ~~used in~~lighter, stronger and tougher, helping to create a wide variety of end applications, such as commercial and military aircraft, space launch vehicles and satellites, wind turbine blades, automotive, recreational products, and other industrial applications.better world for us all.

We serve international markets through manufacturing facilities, sales offices and representatives located in the Americas, Asia Pacific, Europe, India, and Africa. We also have a presence in Malaysia where we are a partner in a joint venture which manufactures composite structures for Commercial Aerospace applications.

We are a manufacturer of products within a single industry: Advanced Composites. We have two reportable segments: Composite Materials and Engineered Products. The Composite Materials segment is comprised of our carbon fiber, specialty reinforcements, resin systems, prepregs and other fiber-reinforced matrix materials, and honeycomb core product lines and pultruded profiles. The Engineered Products segment is comprised of lightweight high strength composite structures, RF/EMI and microwave absorbing materials, engineered core and specialty machined honeycomb products with added functionality and 3D thermoplastic ~~printing.~~additive manufacturing.

~~On March 11, 2020,~~The Commercial Aerospace market began to see signs of recovery from the World Health Organization declared the COVID-19 outbreak a pandemic. The pandemic has resulted in governments around the world implementing stringent measures to help control the spread of the virus, including quarantines, travel restrictions, business curtailments, school closures, mandatory vaccinations and other measures. While some of these measures have been lightened or removed, theeconomic impacts of the COVID-19 pandemic ~~continue to be unpredictable and,~~ in ~~some cases, previously lifted measures have been reimplemented or new measures imposed as~~the second half of 2021 which has continued ~~sporadic outbreaks~~into the second quarter of ~~COVID-19 cases occur in various part of the world.~~

~~Since the pandemic began, we have seen the impacts of COVID-19 on our markets and operations, including significant decreases~~2022 with further growth in air ~~traffic, temporary shutdowns of our customers’~~travel and ~~suppliers’ facilities~~customer inventory destocking now largely completed. Despite these improvements, global logistics, supply chains and decreased demand from our customers. In 2020 and through the first nine months of 2021, our operations, margins and results were adversely impacted by lower demand for our products due to substantial reductions in original equipment manufacturer build rates combined withinflationary pressures still remain a ~~move to reduce inventory throughout our supply chain, particularly carbon fiber. The~~challenge. COVID-19 ~~pandemic~~ has had and may continue to have further negative impacts on our operations, supply chain, transportation networks and customers, all of which have and may continue to compress our margins, even after the preventative and precautionary measures that we, other businesses, and governments have taken and may take in the future. The COVID-19 pandemic is adversely affecting the economies and financial markets globally and has contributed to volatile supply and demand conditions affecting prices and volumes in the markets for our products, services and raw materials, which could continue for an extended period of time.are taking.

~~The extent~~We are also continuing to ~~which COVID-19 continues to adversely impact~~monitor developments in the ongoing conflict between Russia and Ukraine including the related export controls and resulting sanctions imposed on Russia by the U.S. and other countries. Although we do not presently foresee direct material adverse effects upon our business, ~~depends on future developments, including availability~~the global implications of ~~effective vaccines and medical treatments for all age groups and~~ the ~~rate of vaccinations and their effectiveness against new variants of COVID-19, as well as any other new information concerning the effectiveness of actions taken globally~~Russian/Ukraine conflict are difficult to contain or mitigate the effects of COVID-19 and the emergence and impact of new variants of COVID-19. While we expect the pandemic to continue to negatively impact our results of operations, cash flows and financial position, the current level of uncertainty over the economic and operational impacts of COVID-19 means the continuing financial impact to us cannot be reasonably estimatedpredict at this time. Factors such as increased inflation, escalating energy costs, constrained raw material availability, and thus increasing costs, and embargos on flights from Russian airlines could impact the global economy and the aerospace industry in particular.

The Company uses non-GAAP financial measures, including sales and expenses measured in constant dollars (prior year sales and expenses measured at current year exchange rates); operating income, net income and earnings per share adjusted for items included in operating expense and non-operating expenses; and free cash flow. Management believes these non-GAAP measurements are meaningful to investors because they provide a view of Hexcel with respect to ongoing operating results and comparisons to prior periods. These adjustments can represent significant charges or credits that we believe are important to an understanding of Hexcel’s overall operating results in the periods presented. Such non-GAAP measurements are not determined in accordance with generally accepted accounting principles and should not be viewed in isolation or as an alternative to or substitutes for GAAP measures of performance. Our calculation of these measures may not be comparable to similarly titled measures used by other companies, and the measures exclude financial information that some may consider important in evaluating our performance. Reconciliations to adjusted operating income, adjusted net income, adjusted diluted net income per share and free cash flow are provided below.

The following table summarizes net sales to third-party customers by segment and end market for the quarters ended June 30, 2022 and ~~nine months ended September 30, 2021 and 2020:~~2021:


	Quarter Ended September 30,							Nine Months Ended September 30,							Quarter Ended June 30,							Six Months Ended June 30,
(In millions)	2021		2020		% Change			2021		2020		% Change			2022		2021		% Change			2022		2021		% Change
Consolidated Net Sales	$	333.8	$	286.9		16.3	%	$	964.4	$	1,206.6		(20.1	)%	$	393.0	$	320.3		22.7	%	$	783.6	$	630.6		24.3	%
Commercial Aerospace		167.2		128.8		29.8	%		468.5		695.6		(32.6	)%		227.6		153.7		48.1	%		446.5		301.3		48.2	%
Space & Defense		110.4		108.8		1.5	%		329.0		328.8		0.1	%		111.9		106.9		4.7	%		230.1		218.6		5.3	%
Industrial		56.2		49.3		14.0	%		166.9		182.2		(8.4	)%		53.5		59.7		(10.4	)%		107.0		110.7		(3.3	)%

Composite Materials	$	254.1	$	215.7		17.8	%	$	732.2	$	960.4		(23.8	)%	$	318.1	$	240.9		32.0	%	$	631.9	$	478.1		32.2	%
Commercial Aerospace		125.6		95.6		31.4	%		354.5		567.6		(37.5	)%		192.0		116.4		64.9	%		376.8		228.9		64.6	%
Space & Defense		73.5		71.9		2.2	%		214.3		214.5		(0.1	)%		73.9		66.0		12.0	%		150.5		140.8		6.9	%
Industrial		55.0		48.2		14.1	%		163.4		178.3		(8.4	)%		52.2		58.5		(10.8	)%		104.6		108.4		(3.5	)%

Engineered Products	$	79.7	$	71.2		11.9	%	$	232.2	$	246.2		(5.7	)%	$	74.9	$	79.4		(5.7	)%	$	151.7	$	152.5		(0.5	)%
Commercial Aerospace		41.6		33.2		25.3	%		114.0		128.0		(10.9	)%		35.6		37.3		(4.6	)%		69.7		72.4		(3.7	)%
Space & Defense		36.9		36.9		—			114.7		114.3		0.3	%		38.0		40.9		(7.1	)%		79.6		77.8		2.3	%
Industrial		1.2		1.1		9.1	%		3.5		3.9		(10.3	)%		1.3		1.2		8.3	%		2.4		2.3		4.3	%

Composite Materials: Net sales of ~~$254.1~~$318.1 million in the ~~third~~second quarter of ~~2021~~2022 increased by ~~$38.4~~$77.2 million or 32.0% from ~~$215.7 million in~~ the prior year quarter. ~~The increase~~Commercial Aerospace sales increased $75.6 million or 64.9% in ~~sales was largely driven by~~the second quarter of 2022 as compared to the prior year quarter primarily due to stronger narrowbody and A350 sales ~~in Commercial Aerospace~~ as well as ~~an increase in Industrial sales, primarily in the automotive and recreation markets.~~business jet growth. Net sales of ~~$732.2~~$631.9 million for the first ~~nine~~six months of ~~2021 decreased 23.8% compared to the same period last year as the impact of the pandemic did not take effect until the second quarter of 2020.~~2022 increased

~~Engineered Products:~~ ~~Net sales of $79.7 million for the third quarter of 2021 increased $8.5 million as compared to $71.2 million for the third quarter of 2020 due to an increase in Commercial Aerospace sales.~~ ~~Net sales of $232.2 million for the first nine months of 2021 decreased 5.7%~~32.2% compared to the same period last year.

Engineered Products: For the second quarter of 2022, net sales of $74.9 million decreased $4.5 million or 5.7% as compared to the prior year quarter. The decrease was primarily driven by slightly lower Space & Defense sales which were down $2.9 million or 7.1% in the second quarter of 2022 as compared to the same period in 2021. Net sales of $151.7 million for the first six months of 2022 were relatively flat compared to the same period last year.

Commercial Aerospace sales of ~~$167.2~~$227.6 million increased ~~$38.4~~$73.9 million or ~~29.8% (also 29.8%~~48.1% (49.5% in constant currency) for the ~~third~~second quarter of 2022 compared to the second quarter of 2021 led by growth in the A350 and A320neo programs as well as the 737 MAX program. Other Commercial Aerospace, which includes business jets and regional aircraft, increased 75.4% for the second quarter of 2022 compared to the ~~third~~second quarter of ~~2020 on stronger narrowbody sales.~~2021. Sales were significantly lower in the prior year period for most programs as channel destocking was still occurring. Sales of ~~$468.5~~$446.5 million for the first ~~nine~~six months of ~~2021, decreased 32.6% (33.0%~~2022, increased 48.2% (49.3% in constant currency) compared to the first ~~nine~~six months of ~~2020.~~2021 ~~Sales were higher~~due to stronger narrowbody and A350 sales whereas sales in the prior year period ~~as the impact~~were impacted by channel destocking. Sales of ~~production cuts~~Other Commercial Aerospace, which includes business jets and ~~destocking due to the pandemic did not begin to occur until the second quarter of 2020.~~

~~Sales to “Other Commercial Aerospace,” which include~~ regional ~~and business~~ aircraft, increased ~~by 9.4%~~72.9% for the ~~third quarter~~first six months of ~~2021 compared to the third quarter of 2020 primarily due to growth in business jet sales. Sales for the nine months ended September 30, 2021 decreased 28.6% as~~2022 compared to the same period in ~~2020.~~2021.

Space & Defense sales of ~~$110.4~~$111.9 million increased ~~1.5% (1.4%~~4.7% (7.0% in constant currency) for the ~~third~~second quarter of ~~2021 as~~2022 compared to the ~~third~~second quarter of ~~2020 driven by strength in F-35, CH-53K, civil helicopters in Europe and unmanned aerial vehicles in the U.S.~~2021 led by growth in Space, CH-53K heavy lift helicopters and a number of overseas programs. Sales of ~~$329.0~~$230.1 million for the first ~~nine~~six months of ~~2021 were unchanged (0.8% lower~~2022 increased 5.3% (7.0% in constant currency) compared to the first ~~nine~~six months of ~~2020.~~2021 due to growth in Space and the CH-53K program.

Total Industrial sales in the ~~third~~second quarter of ~~2021~~2022 of ~~$56.2~~$53.5 million ~~increased 14.0 % (11.7%~~decreased 10.4% (3.5% in constant currency) compared to the ~~third~~second quarter of ~~2020. Strength in automotive and recreation markets~~2021 as ~~well as sales growth supported by actions to direct carbon fiber~~

~~to other industrial markets offset~~ lower wind energy sales was only partially offset by growth in automotive, recreation and other industrial sales. Wind energy sales (the largest submarket in Industrial), experienced a decline of 29.8% (31.6% in constant currency) during the third quarter of 2021 compared to the third quarter of 2020 due to cessation of sales in North America and subdued demand. Total Industrial sales of ~~$166.9~~$107.0 million for the ~~nine~~six months ~~ended September 30, 2021~~of 2022, decreased ~~8.4% (12.4%~~3.3% (2.6% increase in constant currency) compared to the first ~~nine months of 2020.For the first nine~~six months of 2021 despite growth in automotive, recreation and other industrial markets which was not enough to offset the negative impact of lower wind energy sales.

Gross margin for the second quarter of 2022 was 22.8% compared to 19.3% in the second quarter of 2021 and was 22.5% and 18.2% for the first six months of 2022 and 2021, respectively. The improvements in the gross margin for both the second quarter and first six months of 2022 compared to the same periods last year was primarily due to the higher sales ~~decreased 37.6% (40.3% in constant currency)~~and greater capacity utilization which led to improved cost absorption.

Selling, general and administrative expenses were higher for the second quarter of 2022 compared to the same period ~~last year reflecting~~in 2021, although the current quarter expenses were lower ~~demand~~as a percentage of sales. The increase in selling, general and ~~the cessation of sales in North America.~~

~~Gross margin~~administrative expenses for the ~~third~~current quarter was primarily driven by higher employee compensation reflecting the increase in global headcount. Research and technology expenses were relatively flat compared to the prior year quarter. Selling, general and administrative expenses were higher for the first six months of ~~2021 and 2020 was 19.8% and 4.7%, respectively. The improvement in the third quarter of 2021~~2022 compared to the same period ~~last year was~~in 2021, although lower as a percentage of sales, due to ~~a favorable sales mix oriented towards carbon fiber combined with~~higher employee compensation reflecting the ~~benefits of prior cost reduction actions that reduced the overhead cost base. Gross margin~~increase in global headcount. Research and technology expenses for the first ~~nine~~six months of ~~2021 and 2020 was 18.8% and 17.3%, respectively.~~

~~Selling, general and administrative and research and technology expenses~~2022 were ~~higher for both the third quarter and nine months ended September 30, 2021~~slightly lower compared to the ~~same periods in 2020, primarily due an increase in employee-related costs as the~~ prior year ~~period included benefits from~~due to lower ~~stock compensation expense and temporary salary reductions.~~depreciation expense.

Operating income ~~(loss)~~ for the ~~third~~second quarters of 2022 and 2021 ~~and 2020~~ was ~~$22.8~~$63.8 million and ~~$(37.6)~~$16.2 million, respectively. Operating income for the first six months of 2022 was $93.9 million compared to $6.0 million for the same period last year. The increase in operating income for both the ~~third~~second quarter and six months of ~~2021~~2022 over the same ~~period~~periods last year was primarily driven by higher sales and strong gross margins ~~resulting from favorable sales mix and a reduction in the overhead cost base,~~ as well as the gain on the sale of our Dublin, California facility and lower ~~severance~~restructuring costs. Operating income for the first nine months of 2021 and 2020 was $28.8 million and $34.5 million, respectively. The decrease in operating income for the nine months ended September 30, 2021 as compared to the same period last year was largely due to lower gross margins resulting from a pandemic-related decline in sales partially offset by lower other operating expenses due to lower severance in 2021 and costs incurred in 2020 related to the terminated merger with Woodward, Inc.

Interest expense for both the ~~third~~ quarter ~~ended September 30, 2021 was slightly lower compared to the third quarter of 2020~~ and ~~interest expense for the nine~~six months ended ~~September~~June 30, ~~2021~~2022 was lower compared to the ~~same period last~~prior year ~~primarily~~periods due to lower average debt ~~levels.~~levels, partially offset by higher interest rates.

The ~~effective~~ tax ~~rate~~expense for the quarter ended ~~September~~June 30, ~~2021~~2022 was ~~38.3% and~~$12.7 million compared to $4.0 million for the second quarter of 2021. The quarter ended June, 2021 included a discrete tax charge of ~~$1.3~~$2.7 million related to the remeasurement of the net ~~state~~ deferred tax ~~liabilities. The~~liability in a foreign tax jurisdiction as a result of an unfavorable tax rate change. Tax expense for the ~~nine~~first six months ended ~~September~~June 30, ~~2021~~2022 was ~~$1.6~~$17.4 million ~~and included~~compared to a ~~net discrete tax charge~~benefit of ~~$0.8~~$3.5 million ~~resulting from~~for the ~~revaluation~~same period of ~~U.S. and foreign deferred tax liabilities.~~2021. The tax benefit for the ~~quarter~~six months ended ~~September~~June 30, ~~2020 was $56.9 million and~~2021 included a ~~$46.2 million~~discrete tax benefit ~~primarily due~~related to a favorable U.S state tax law change in addition to the ~~release of a valuation allowance in a foreign jurisdiction due to a legal entity rationalization and treasury realignment initiative. The~~discrete tax ~~benefit of $48.7 million for the first nine months of 2020 also included a $2.7 million benefit for the release of reserves of unrecognized tax benefits as a result of tax audit settlements.~~charge previously mentioned.

Liquidity: Cash on hand at ~~September~~June 30, ~~2021~~2022 was ~~$105.8~~$99.2 million as compared to ~~$103.3~~$127.7 million at December 31, ~~2020.~~2021. As of ~~September~~June 30, ~~2021,~~2022, total debt was ~~$877.3~~$812.5 million as compared to ~~$926.4~~$823.3 million at December 31, ~~2020.~~2021.

In September 2020, we amended our Facility to allow for relief from certain terms, including adjusting the maximum leverage ratio covenant for a defined period. On January 28, 2021, we entered into the Second Amendment, which further amended the Facility agreement to provide that, from January 28, 2021 through and including March 31, 2022, we ~~will~~would not be subject to a maximum leverage ratio covenant but ~~will~~ instead be required to maintain Liquidity (as defined in the Facility agreement) of at least $250 million. ~~Additionally, during such period,~~Effective April 1, 2022, the ~~Company~~original terms and conditions to the Facility agreement were reinstated except the borrowing capacity which will ~~be subject to limitations on~~remain at $750 million. As a result, share repurchases ~~cash dividends, and its ability to incur secured debt,~~restrictions that had been in each case subject to certain exceptions; the applicable margin and commitment fees are increased; the incremental facility will not be available; and if the Company’s public debt rating is downgraded to (i) BB or lower by Standard & Poor’s and (ii) Ba2 or lower by Moody’s, we will be required to grant liens on certain of our assets, which liens will be released upon the Company’s public debt rating being upgraded to BB+ or higher by Standard & Poor’s or Ba1 or higher by Moody’s. The Company’s public debt rating as of September 30, 2021 is BB+/Baa3. In addition,effect per the Second Amendment ~~provides that the Company will not be subject to an interest coverage ratio covenant until the test period ending December~~expired on March 31, ~~2021 and revolving commitments~~2022. The remaining authorization under the ~~Facility were reduced to $750~~share repurchase program at June 30, 2022 was $217 million. In connection with the Second Amendment, we accelerated a portion of the deferred financing costs and recognized $0.9 million in interest expense during the first quarter of 2021. As of September 30, 2021, we were in compliance with all debt covenants.

As of ~~September~~June 30, ~~2021,~~2022, total borrowings under the Facility were ~~$179.0~~$114 million, which approximated fair value. The Facility agreement permits us to issue letters of credit up to an aggregate amount of $50 million. Outstanding letters of credit reduce the amount available for borrowing under the Facility. As of ~~September~~June 30, ~~2021,~~2022, there were no issued letters of credit under the Facility, resulting in undrawn availability under the Facility of ~~$571~~$636 million. The weighted average interest rate for the Facility was ~~4.16%~~4.2% for the ~~nine~~six months ended ~~September~~June 30, ~~2021.~~2022.

We expect to meet our short-term liquidity requirements (including capital expenditures) through net cash from operating activities, cash on hand and the Facility. As of ~~September~~June 30, ~~2021,~~2022, long-term liquidity requirements consist primarily of obligations under our long-term debt obligations. We do not have any significant required debt repayments until June 2024 when the Facility expires.

In 2021, the Company applied for the Aviation Manufacturing Jobs Protection ("AMJP") program, created under the American Rescue Plan Act of 2021, which provides funding to eligible businesses to pay up to half of their compensation costs for certain categories of employees, for up to six months. To qualify for funding, eligible companies must have involuntarily furloughed or laid off at least 10% of its U.S. workforce or have experienced at least a 15% decline in 2020 global operating revenue. In September 2021, the U.S. Department of Transportation announced that it had approved for the Company to receive up to $20.9 million

under the AMJP program. The Company ~~anticipates receiving approximately half~~received $10.5 million of the offered funds in the fourth quarter of 2021 and anticipates receiving the remaining funds in 2022.

On July 25, 2022, our Board of Directors declared a quarterly dividend of $0.10 per share payable to stockholders of record as of August 5, 2022, with a payment date of August 12, 2022.

Operating Activities: Net cash provided by operating activities for the first ~~nine~~six months of ~~2021~~2022 was ~~$64.2~~$18.3 million compared to ~~$157.0~~$38.9 million for the same period last year. Working capital was a cash use of ~~$46.0~~$95.1 million for the first ~~nine~~six months of ~~2021~~2022 compared to a ~~source~~use of ~~$28.7~~$19.6 million in the same period in ~~2020.~~2021 primarily driven by higher inventory and accounts receivable to support higher sales.

Investing Activities: Net cash used for investing activities was ~~$15.0~~$16.2 million and ~~$47.8~~$9.2 million in the first ~~nine~~six months of 2022 and 2021, ~~and 2020, respectively, reflecting a decline in capital expenditures.~~

~~Financing Activities:~~ ~~Financing activities used $44.8~~respectively. The first six months of 2022 included net proceeds of approximately $21.2 million from the sale of ~~cash in~~our Dublin, California facility. Capital expenditures for the first ~~nine~~six months of ~~2021~~2022 were $37.9 million compared to ~~$106.9~~$9.2 million in the same period in ~~2020. In response~~2021. The increase in capital expenditures is primarily driven by two ongoing construction projects for the previously announced construction of a research and technology innovation center in Salt Lake City, Utah. and the expansion of Hexcel’s facility in Morocco.

Financing Activities: Net cash used for financing activities was $26.6 million for first six months of 2022 compared to ~~the impacts of the COVID-19 pandemic, we announced~~$16.6 million in the same period in 2021. Borrowings under the Facility during the first six months of 2022 was $35.0 million, while repayments were $46.0 million compared to $21.0 million in the prior year. In the first quarter of 2022, we reinstated our quarterly dividend payment, which had previously been suspended as of early ~~part of 2020 that we had suspended our~~2020. $16.8 million in dividend payments ~~and stock repurchases. During the third quarter ended September 30, 2020, we repaid $266 million under our Facility although borrowings~~ were ~~higher in 2020 as they included the remaining $125 million of our initial exceptional drawdown of $250 million, which we chose~~made to ~~draw down as we focused on preserving cash~~shareholders during our initial response to the COVID-19 pandemic. In addition, in January 2020, the Company used $49.9 million to repay and terminate its Euro term loan. We also returned $38.8 million to stockholders in the form of stock repurchases and dividends in the first ~~half~~six months of ~~2020.~~

Financial Obligations and Commitments: The next significant scheduled debt maturity will not occur until 2024, when the Facility matures. Certain sales and administrative offices, data processing equipment and manufacturing facilities are leased under operating leases.

Our Condensed Consolidated Financial Statements are prepared in accordance with U.S. GAAP. In connection with the preparation of our financial statements, we are required to make assumptions and estimates about future events, and apply judgments that affect reported amounts of assets, liabilities, revenues, expenses and related disclosures. We base our assumptions, estimates and judgments on historical experience, current trends and other factors management believes to be relevant at the time our Condensed Consolidated Financial Statements are prepared. On a regular basis, management reviews accounting policies, assumptions, estimates and judgments to ensure our financial statements are presented fairly and in accordance with U.S. GAAP. However, because future events and their effects cannot be determined with certainty, actual results may differ from our assumptions and estimates, and such differences could be material.

We describe our significant accounting policies and critical accounting estimates in our Annual Report on Form 10-K for the fiscal year ended December 31, ~~2020.~~2021.

We are involved in litigation, investigations and claims arising out of the normal conduct of our business, including those relating to commercial transactions, environmental, employment and health and safety matters. We estimate and accrue our liabilities resulting from such matters based upon a variety of factors, including the stage of the proceeding; potential settlement value; assessments by internal and external counsel; and assessments by environmental engineers and consultants of potential environmental liabilities and remediation costs. We believe we have adequately accrued for these potential liabilities; however, facts and circumstances may change, such as new developments, or a change in approach, including a change in settlement strategy or in an environmental remediation plan, or in our existing insurance coverage, that could cause the actual liability to exceed the estimates, or may require adjustments to the recorded liability balances in the future. For further discussion, see Note ~~12,~~11, Commitments and Contingencies, to the accompanying Condensed Consolidated Financial Statements of this Form 10-Q.

The Company uses non-GAAP financial measures, including sales and expenses measured in constant dollars (prior year sales and expenses measured at current year exchange rates); operating income, net income and earnings per share adjusted for items included in operating expense and non-operating expenses; and free cash flow. Management believes these non-GAAP measures are meaningful to investors because they provide a view of Hexcel with respect to ongoing operating results and comparisons to prior periods. These adjustments can represent significant charges or credits that we believe are important to an understanding of Hexcel’s overall operating results in the periods presented. Such non-GAAP measures are not determined in accordance with generally accepted accounting principles and should not be viewed in isolation or as an alternative to or substitutes for GAAP measures of performance. Our calculation of these measures may not be comparable to similarly titled measures used by other companies, and the measures exclude financial information that some may consider important in evaluating our performance. Reconciliations to adjusted operating income, adjusted net income, adjusted diluted net income per share and free cash flow are provided below.

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to analyses and other information that are based on forecasts of future results and estimates of amounts not yet determinable. These statements also relate to future prospects, developments and business strategies. These forward-looking statements are identified by their use of terms and phrases such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,”" "seek," “target,” “would,” “will” and similar terms and phrases, including references to assumptions. Such statements are based on current expectations, are inherently uncertain and are subject to changing assumptions.

Such forward-looking statements include, but are not limited to: (a) the estimates and expectations based on aircraft production rates provided by Airbus, Boeing and others; (b) the revenues we may generate from an aircraft model or program; (c) the impact of the ~~possible~~ push-out in deliveries of the Airbus and Boeing backlog and the impact of delays in the startup or ramp-up of new aircraft programs or the final Hexcel composite material content once the design and material selection have been completed; (d)expectations with regard to regulatory clearances or the build rate of the Boeing 737 MAX ~~following its return to service~~or Boeing 787 and the related impact on our revenues; (e) ~~expectations with regard to the timing of inventory destocking resulting from the pandemic-induced decrease in customer demand; (f)~~ expectations with regard to raw material cost and availability; ~~(g)~~(f) expectations of composite content on new commercial aircraft programs and our share of those requirements; ~~(h)~~(g) expectations regarding revenues from space and defense applications, including whether certain programs might be curtailed or discontinued; ~~(i)~~(h) expectations regarding sales for wind energy, recreation, automotive and other industrial applications; ~~(j)~~(i) expectations regarding working capital trends and expenditures and inventory levels; ~~(k)~~(j) expectations as to the level of capital expenditures and completion of capacity expansions and qualification of new products; ~~(l)~~(k) expectations regarding our ability to improve or maintain ~~and improve~~ margins; ~~(m)~~(l) expectations regarding the outcome of legal matters or the impact of changes in laws or regulations or government policies; ~~(n)~~(m) our projections regarding our tax rate; ~~(o)~~(n) expectations with regard to the continued impact of the COVID-19 pandemic and the impact of the conflict between Russia and Ukraine on worldwide air travel and aircraft programs, as well as on our customers and suppliers and, in turn, on our operations and financial results; (o) expectations regarding our strategic initiatives and other goals, including, but not limited to, our sustainability goals; (p) expectations regarding the sale of certain of our assets; and (q) the anticipated impact of the above factors and various market risks on our expectations of financial results for ~~2021~~2022 and beyond.

Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different. Such factors include, but are not limited to, the following: the impact of the COVID-19 pandemic (including continued disruption in global financial markets and supply chains, ongoing restrictions on movement and travel, employee

absenteeism and labor shortages, and reduced demand for air travel) on the operations, business and financial condition of Hexcel and its customers and suppliers; reductions in sales to any significant customers, particularly Airbus or Boeing, including ~~reduction in revenue~~ related to the timing of ~~ramp-up of production of~~pending regulatory clearances for the Boeing 737 MAX and the Boeing 787, as well as due to the impact of the COVID-19 pandemic; our ability to effectively adjust production and inventory levels to align with customer demand; ~~inability~~our ability to effectively motivate, retain and hire the necessary workforce; our ability to successfully implement or realize our business strategies, plans, goals and objectives of management, including our sustainability goals and any restructuring or alignment activities in which we may engage; the impact of any government mandated COVID-19 precautions, including mandatory vaccination; ~~timing of inventory destocking caused by the COVID-19 pandemic;~~ changes in sales mix; changes in current pricing and cost ~~levels;~~ levels, including cost inflation, as well as increasing energy prices resulting from the conflict between Russia and Ukraine;changes in aerospace delivery rates; changes in government defense procurement budgets; changes in military aerospace program technology; timely new product development or introduction; industry capacity; increased competition; availability and cost of raw ~~materials;~~materials, including the impact of supply shortages and inflation; supply chain ~~disruptions; our ability~~disruptions, which may be exacerbated by the conflict between Russia and Ukraine; inability to install, staff and qualify necessary capacity or complete capacity expansions to meet customer demand; ~~cybersecurity~~cybersecurity-related risks, including the potential impact of breaches or intrusions; currency exchange rate fluctuations; changes in political, social and economic conditions, including, but not limited to, the effect of change in global trade policies, ~~and the impact~~such as sanctions imposed as a result of the ~~exit of the U.K. from the European Union;~~conflict between Russia and Ukraine; work stoppages or other labor disruptions; our ability to successfully complete any strategic acquisitions, investments or dispositions; compliance with environmental, health, safety and other related laws and regulations, including those related to c~~limate~~climate change; the effects of natural disasters, which may be worsened by the impact of climate change,; and other severe catastrophic events; the potential impact of environmental, social and governance matters; and the unexpected outcome of legal matters or impact of changes in laws or regulations.

Although we believe that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect our actual results of operations and could cause actual results to differ materially from those expressed in the forward-looking statements. As a result, the foregoing factors should not be construed as exhaustive and should be read together with other cautionary statements included in this and other reports we file with the SEC. For additional information regarding certain factors that may cause our actual results to differ from those expected or anticipated, see the information under the caption “Risk ~~Factors”~~Factors,” which is located in Item 1A of Part I of our Annual Report on Form 10-K for the fiscal year ended December 31, ~~2020, as well as in Item 1A. “Risk Factors” of this Form 10-Q.~~2021. We do not undertake any obligation to update our forward-looking statements or risk factors to reflect future events or circumstances, except as otherwise required by law.

Except for the continued broad effects of COVID-19 and the Russian/Ukraine conflict on market risk, there have been no material changes in our market risk from the information provided in the Company’s Annual Report on Form 10-K for the year ended December 31, ~~2020.~~2021.

Our Chief Executive Officer and Chief Financial Officer have evaluated our disclosure controls and procedures as of ~~September~~June 30, ~~2021,~~2022, and with the participation of the Company's management have concluded that these disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. These disclosure controls and procedures include, without limitation, controls and procedures designed to

ensure that information required to be disclosed by us in the reports we file or submit is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Our Chief Executive Officer and Chief Financial Officer have concluded that there have not been any changes in our internal control over financial reporting during the three months ended ~~September~~June 30, ~~2021~~2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

The information required by Item 1 is contained within Note 1211 on pages 1615 through 1716 of this Form 10-Q and is incorporated herein by reference.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2020,~~2021, which could materially affect our business, financial condition or future results. There have been no material changes in the ~~Company’s~~Company's risk factors from the aforementioned 10-K, except as set forth in the below risk factor, and the risk factor entitled “The short-term rights agreement that we entered into in 2020 could discourage third parties from seeking strategic transactions with us that could be beneficial to our stockholders.” is no longer applicable as our stockholder rights plan expired on April 6, 2021.

~~Our business has been and will continue to be adversely affected by the COVID-19 pandemic. The full extent to which the COVID-19 pandemic will adversely impact our business, financial condition and results of operations is highly uncertain and cannot be predicted.~~

In March 2020, the World Health Organization characterized the outbreak of COVID-19 as a pandemic. The COVID-19 pandemic has created significant uncertainty and economic disruption and has negatively affected the business and results of operations for the Company. We have taken steps to align our business with the unfavorable economic conditions, including headcount reductions, reductions in employee hours, and/or furloughs, at many of our sites. Given the ongoing and dynamic nature of the pandemic, it is difficult to predict the full extent of the adverse impact of the COVID-19 pandemic on our business, and there is no guarantee our efforts to address the adverse impacts of COVID-19 will be effective.

We have experienced lower demand and operational interruptions as a result of COVID-19, including the temporary suspension of operations due to the inability to staff facilities or government-imposed restrictions, which has had an adverse effect on the productivity and profitability of such manufacturing facilities, and in turn an adverse effect on our business and operations. While most of our manufacturing sites are currently in operation, we have reduced or furloughed certain operations in response to government measures, employee welfare concerns and the impact of COVID-19 on the global demand and supply chain. Our manufacturing operations may be further adversely affected by impacts from COVID-19 including, among other things, additional government actions and other responsive measures, further decreases in demand and/or deeper supply chain disruptions, and health and availability of essential onsite personnel.

We are heavily dependent on sales to customers in the aerospace industry, which has been materially negatively impacted by the COVID-19 pandemic. Approximately 55% of our sales for fiscal year ended December 31, 2020 were derived from sales to Commercial Aerospace customers, which included 84% from Airbus and Boeing aircraft, and 16% from regional and business aircraft. Travel restrictions, as well as changes in the propensity for the general public to travel by air as a result of the COVID-19 pandemic, have caused reductions in demand for commercial aircraft, which has had an adverse impact our sales and operating results and may continue to do so for an extended period of time. While we are unable to predict the magnitude and duration of such and impact at this time, the further loss of, or significant reduction in, purchases by Airbus or Boeing will materially impair our business, operating results, prospects, and financial condition.

Furthermore, the COVID-19 pandemic has resulted in market volatility, which caused a significant decline in our stock price, subjecting us to increased takeover risk, impaired our ability to declare dividends or other distributions and conduct share buybacks, and may impact our ability to comply with the covenants contained in the agreements that govern our indebtedness and raise additional funds when and as needed. We may also incur additional costs to remedy damages caused by business disruptions,

performance delays or interruptions, payment defaults or bankruptcy of our third-party customers and suppliers, which could lead to additional charges, impairments, and other adverse financial impacts.

On September 9, 2021, President Biden directed the Department of Labor’s Occupational Safety and Health Administration (“OSHA”) to issue an Emergency Temporary Standard (“ETS”) requiring that all employers with at least 100 employees ensure that their employees are fully vaccinated for COVID-19 or obtain a negative COVID-19 test at least once a week. President Biden also issued an Executive Orderrequiring certain COVID-19 precautions for government contractors and their subcontractors, including mandatory employee vaccination (subject to medical and religious exemptions). It is not currently possible to predict with any certainty the exact impact on the Company of the OSHA ETS, which has not yet been issued, or the requirements for government contractors and their subcontractors. Any requirement to mandate COVID-19 vaccination of our workforce or require our unvaccinated employees to be tested weekly could result in employee attrition and difficulty securing future labor needs and may have an adverse effect on future profit margins. In addition, any requirement to impose obligations on our suppliers under the Executive Order covering government contractors and their subcontractors could impact the price and continuity of supply of raw materials and our results of operations and financial condition could be adversely affected.

We cannot predict at this time the full extent to which the COVID-19 pandemic will adversely impact our business, results, and financial condition, which will depend on many factors that are not known at this time, as the situation is unprecedented and continues to evolve. These include, among others, the extent of harm to public health, including the duration of the pandemic, any potential subsequent waves of COVID-19 infection, the emergence of new variants of COVID-19, which may be more transmissible or virulent than the initial strain, the availability of effective vaccines and medical treatments for all age groups and the rate of vaccinations, further disruption to the manufacturing of and demand for our products, our ability to effectively manage raw material supply and inventory levels and to adjust our production schedules to align with changing demand, potential future restructuring actions, impairments and other charges, the impact of the global business and economic environment on liquidity and the availability of capital, the costs incurred to keep our employees safe and comply with government requirements while maintaining continued operations, and our ability to effectively motivate and retain the necessary workforce. Even after the COVID-19 pandemic has subsided, we may continue to experience adverse impacts to our business as a result of its global economic impact and the impact on air travel.

~~In addition to the foregoing, many of the risk factors disclosed in Part I, Item 1A, “Risk Factors,” of our Annual Report on~~ Form ~~10-K have been, and we anticipate will continue to be further, heightened or exacerbated by the impact of the COVID-19 pandemic.~~

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Delaware		94-1109521
(State or Other Jurisdiction of Incorporation or Organization)		(I.R.S. Employer Identification No.)


Large accelerated filer 		Accelerated filer 
Non-accelerated filer 		Smaller reporting company ☐
		Emerging growth company ☐


Class		Outstanding at ~~October 14, 2021~~July 21, 2022
COMMON STOCK		~~83,894,367~~84,102,467


			Page
PART I.	FINANCIAL INFORMATION		3

ITEM 1.	Condensed Consolidated Financial Statements (Unaudited)		3

	•		~~Condensed Consolidated Balance Sheets — September 30, 2021 and December 31, 2020~~	3

	•	Condensed Consolidated ~~Statements of Operations~~Balance Sheets — ~~The quarter~~June 30 2022, and ~~nine months ended September 30,~~December 31, 2021 ~~and 2020~~	43

	•	Condensed Consolidated Statements of ~~Comprehensive Income (Loss)~~Operations — The quarter and ~~nine~~six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020~~2021	4

	•	Condensed Consolidated Statements of ~~Cash Flows~~Comprehensive (Loss) Income — The ~~nine~~quarter and six months ended ~~September~~June 30, ~~2021~~2022 and ~~2020~~2021	54

	•	~~Condensed Consolidated Statements of Stockholders’ Equity — The quarter and nine months ended September 30, 2021 and 2020~~	6

	•	Condensed Consolidated Statements of Cash Flows — The six months ended June 30, 2022 and 2021	5

	•	Condensed Consolidated Statements of Stockholders’ Equity — The quarter and six months ended June 30, 2022 and 2021	6

	•	Notes to Condensed Consolidated Financial Statements	7

ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		1918

ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk		2524

ITEM 4.	Controls and Procedures		2524

PART II.	OTHER INFORMATION		2625

ITEM 1.	Legal Proceedings		2625

ITEM 1A.	Risk Factors		2625

ITEM 6.	Exhibits		2826

	SIGNATURE		2927


(In millions)	Unrecognized Net Defined Benefit and Postretirement Plan Costs			Change in Fair Value of Derivatives Products (1)			Foreign Currency Translation			Total
Balance at December 31, 2021	$	(61.7	)	$	(3.1	)	$	(61.7	)	$	(126.5	)
Other comprehensive income (loss) before reclassifications		6.9			(20.4	)		(50.5	)		(64.0	)
Amounts reclassified from accumulated other comprehensive loss		0.8			(1.6	)	—				(0.8	)
Other comprehensive income (loss)		7.7			(22.0	)		(50.5	)		(64.8	)
Balance at June 30, 2022	$	(54.0	)	$	(25.1	)	$	(112.2	)	$	(191.3	)


Hexcel Corporation and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income (Loss)

	(Unaudited)						(Unaudited)
	Quarter Ended September 30,						Nine Months Ended September 30,
(In millions)	2021			2020			2021			2020
Net income (loss)	$	9.0		$	9.7		$	(2.8	)	$	51.1
Currency translation adjustments		(14.5	)		38.7			(22.3	)		22.7
Net unrealized pension and other benefit actuarial gains (losses) and prior service credits (net of tax)		1.0			(1.0	)		(0.9	)		(0.2	)
Net unrealized (losses) gains on financial instruments (net of tax)		(7.1	)		15.1			(11.0	)		11.0
Total other comprehensive (loss) income		(20.6	)		52.8			(34.2	)		33.5
Comprehensive (loss) income	$	(11.6	)	$	62.5		$	(37.0	)	$	84.6


			Activity for the Quarter Ended September 30, 2021
	June 30,		Restructuring					Cash						September 30,
(In Millions)	2021		Charge		FX Impact			Paid			Non-Cash			2021
Employee termination	$	12.5	$	0.7	$	(0.3	)	$	(2.6	)	$	—		$	10.3
Impairment and other		—		0.1		0			(0.1	)		0			—
Total	$	12.5	$	0.8	$	(0.3	)	$	(2.7	)	$	0		$	10.3


			Activity for the Nine Months Ended September 30, 2021
	December 31,		Restructuring					Cash						September 30,
(In Millions)	2020		Charge		FX Impact			Paid			Non-Cash			2021
Employee termination	$	14.2	$	11.4	$	(0.6	)	$	(14.7	)	$	—		$	10.3
Impairment and other		—		6.9		0			(3.6	)		(3.3	)		—
Total	$	14.2	$	18.3	$	(0.6	)	$	(18.3	)	$	(3.3	)	$	10.3


Exhibit No.		Description
~~10.1~~10.1*		~~Amendment No. 2~~Form of Performance Based Award Agreement for Executive Officers (2022) (incorporated herein by reference to Exhibit 10.1 to the ~~Supplemental~~Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2022).
10.2*		Form of Performance Based Award Agreement for Non-U.S. Executive ~~Retirement Agreement dated October 28, 2009, between Nick L. Stanage and Hexcel Corporation, effective July 26, 2021~~Officers (2022) (incorporated herein by reference to Exhibit 10.2 to the ~~Company’s~~Company's Quarterly Report on Form 10-Q for the quarter ended ~~June 30, 2021)~~March 31, 2022).*
10.3*		Hexcel Corporation Director Compensation Program
10.4*		Separation Agreement for Robert G. Hennemuth
31.1		Certification of Chief Executive Officer, Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Chief Financial Officer, Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32		Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)
101
~~101~~		The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended ~~September~~June 30 ~~2021,~~31, 2022, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive (Loss) Income, ~~(Loss),~~ (iv) Condensed Consolidated Statements of Cash Flows, (v) Condensed Consolidated Statements of Stockholders’ Equity, and (vi) Notes to Condensed Consolidated Financial Statements.
104		Cover Page Interactive Data File: the cover page XBRL tags are embedded within the Inline XBRL document and are contained within Exhibit 101.


		Hexcel Corporation

~~October 18, 2021~~July 25, 2022		/s/ Amy S. Evans
(Date)		Amy S. Evans
		Senior Vice President,
		Chief Accounting Officer